ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000240.1|Lomaiviticin_1 # 2 # 364 # -1 # ID=1_1;partial=10;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.749	BGC0000240.1|Lomaiviticin_1 	2	364	-	Loose	940	28.4906	mdsC	48.15	3000791	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGCGGAACCGAACCGGCGCCGGTCCGCGGGCTGGTCTCGGCCCGGGCATCCGCGTTGACCAGCAGCCGGCTCGCGCATCTGATGCGGGTGGCGCGCGAGCGCAACGCGATCGATCTCGCGCTGGGCGTTCCCGGCTACCCGGAGCCGCCGGACTGGCGCTACGACCCGCGGGAGCTGACCGCTGCATTCGGCCCGCGGACACGGGCGCTGCTAGTGGCCGACGTGCGGCCGGTCGACGACGAGGGATCCAACGCCTCCGTGCGGCGGACGGGCTACGAGGCGGGAGTGCTGCTCGCGCCGGGGGCGGTCTGCACCGCCGATGCGGCCCGGGGACGGCAGTTCGTCCGGGTGGCGTTCAAT	MSGTEPAPVRGLVSARASALTSSRLAHLMRVARERNAIDLALGVPGYPEPPDWRYDPRELTAAFGPRTRALLVADVRPVDDEGSNASVRRTGYEAGVLLAPGAVCTADAARGRQFVRVAFN	MRTALIRMISKHNDGNGIMKITFTGYRQTATLATLAFVTTLAGCTMAPKHERPASPTAMVYPYATSTVSGAPDAADIGWRDFFHDPLLQELIAIALRNNRDLRKAGLNVEAARALYRIQRAEMLPTLGIATAMDASRTPADLSVMDESEINRRYEAAGATTAWELDLWGRVRSLSDQALAAYMALDETYIAARMSLVSEVASAWLTLRADRELLRLTEDTLAAQKSSYTLTTQLARTGNATQLDLRMAEIALRSAEINRAAYTRQLARDRNALELLLGQPLTPELSRRLNEAVTLTEGAIPTTLPGGLPSDLLVRRPDIRAAEYRLRGANARIGAARAAFFPTISLTGSAGTASASLSGLFEPGSGSWRFLPQITLPLFHGGALRADLDRAHVQKQIEIARYENVIQQAFRDVADGLAGQRTLNDQVQSEQRAVEASQIAYELAGLRFQEGVDDYLTLLDTHRMLYGAQQRLVRTRLMQQLNIINLYKALGGGWREYSEKKQG	24.06	gnl|BL_ORD_ID|1088|hsp_num:0	1180			771	852	chloramphenicol
BGC0000240.1|Lomaiviticin_2 # 361 # 975 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.720	BGC0000240.1|Lomaiviticin_2 	361	975	-	Loose	300	25.7942	AAC(3)-Ib	34.21	3002530	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGCAGGCGATCGAGGCGCACACCGGGCGGATGGCCCCGCTGCGCCGCAACGACGTGGACACCGACCAAATCATCCCCAGCGATTTCTGCCGGCGGCTGACCAAAACGGGATTCGAGGATGGGCTGTTCGCGGGTTGGCGGGCGGACCCGGACTTCGTGCTCAACCGTGAGCCGTACGCGTCCGCGACCGTGCTGGTCGCCCAGCGCAACTTCGGGTCCGGCAGCTCCCGGGAAACCGCGGTGTGGGCCCTGCGGGACTGGGGGTTCGCCGCGGTGATCGCGGAGAGCTTCGGCGACATCTTCCAACGCAACGCGGGCAAGAACGCGCTGCTCGCGGTCGCGCTCGGGGCCGACGCGGTGGGCGCGCTGCTCGACCACGCGACCGAGCGGCCGGACGCCGAGATCACCGTCGACCTGCTCGACCGCCAGGTACGCAGCGAGGTGGGCGTCTGGGACTTCGCCATCGAAGACCGCGCACGGTGGCTGATGCTCAACGGCCTCGACGAGATCGCGGTGACCTTGGGCCGAGACGCGGCCATCCGCGCGCACGAGGCCGCCCGGCCACCGTGGCTGCCGCGGACCGCGGCCCCGACCCGCGCGGTGCCGGTGCCGTGA	MQAIEAHTGRMAPLRRNDVDTDQIIPSDFCRRLTKTGFEDGLFAGWRADPDFVLNREPYASATVLVAQRNFGSGSSRETAVWALRDWGFAAVIAESFGDIFQRNAGKNALLAVALGADAVGALLDHATERPDAEITVDLLDRQVRSEVGVWDFAIEDRARWLMLNGLDEIAVTLGRDAAIRAHEAARPPWLPRTAAPTRAVPVP	MLWSSNDVTQQGSRPKTKLGGSMSIIATVKIGPDEISAMRAVLDLFGKEFEDIPTYSDRQPTNEYLANLLHSETFIALAAFDRGTAIGGLAAYVLPKFEQARSEIYIYDLAVASSHRRLGVATALISHLKRVAVELGAYVIYVQADYGDDPAVALYTKLGVREDVMHFDIDPRTAT	115.91	gnl|BL_ORD_ID|523|hsp_num:0	575			297	411	astromicin; sisomicin; gentamicin
BGC0000240.1|Lomaiviticin_4 # 2379 # 3560 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.700	BGC0000240.1|Lomaiviticin_4 	2379	3560	-	Loose	250	30.0314	arr-7	37.84	3002852	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin ADP-ribosyltransferase (Arr)	ATGACAATTGACCTGGCCGGAAAAGGGGGACGGCGCATCGACATCTTCGATGCGACGCTGCGCGACGGCGAGCAGGCACCGGGGAACACGATGAGCCCCGAGGACAAGCTCCGGTACGCACTGGCGGCCGAGGCCTTCGGTGCCGATGTGATCGAGGCGGGTTTCCCAGCTTCGTCACCAGCCGACTTCGCGGCGACGAAGCTCATCGCCGGCGCACTGACCACCGCGCGGTTCTCCACCTTCAACCGATGCTCCGAGCGGGACATCCGGTTGTCGGCGGAGGCGGGCGGCATTCGGCCCAACCACCAGATCGCCATCTGCGGCACCGGCAGCGACCTGCACCTGGAACACAAGCGCCAGATCACCCGCCGGGAGGCGATTGCCGAGGGACGCCATGCGGTACGTCTGGCGGCAGCGTTGGGGGCCACCGACATCGCGTTCTGCATCGAGGACGCCAGCCGGGGCGACCGCGGCTTCGTCATGGACCTCGTGGGCGAGGCGCTCGCCCAGGGCGCCACCACCATCGGCCTGGCCGACACCACCGGCTGCGCCACCCCGTCCGAATACGGCGACCTGATCGCCGAGGCGCACGAGATGGTGCCGCCGGACGTCACCATCTCGACGCACTGCCACGACGACCTGGGGCTGTCGCTGGCCAACGCGCTGGCCGGGGTGCAGGCAGGCGCCGGCGAGGTGCAGGCCACGCTGGGCGGCATCGGTGAGCGGTGCGGCAACACCCCGCTTGAGGAACTGGCCGCCGTGCTGGTCTTCAAGAGCGCGCAGGTCGGGGCGTACACGGACCTCCGCATCGACCAGCTCTACGCGGCGTACGTGGATCTCGTCGACACGACCGGCATGGCGGTGCCGCGCAACAAGGCCATCGTCGGGCTGAACGCCTTCGCCACCCAGGCCGGGATCCATCAGGACGGCATCCTCAAGAACCCGGCCACGTACGAGTTCATGGACCCGGCCCGTTGGGGACGGCACCGTTCGATCCTCGTCGGGCGGCACTCGGGGCGGGCGGTGGTGCGTTACGTGCTCGCCGAGCTCGGTGCCCCCGAGGACGACGCGCTGGTGGACCGGATGTACGAGGAACTCGTCGCCTCGCGCCCCGGCAGCGACTGCGACGAACTGGACCACCTGCGCGACGAGGTGGCGCTGCGGCTGGCGGTGAGCCCGTGA	MTIDLAGKGGRRIDIFDATLRDGEQAPGNTMSPEDKLRYALAAEAFGADVIEAGFPASSPADFAATKLIAGALTTARFSTFNRCSERDIRLSAEAGGIRPNHQIAICGTGSDLHLEHKRQITRREAIAEGRHAVRLAAALGATDIAFCIEDASRGDRGFVMDLVGEALAQGATTIGLADTTGCATPSEYGDLIAEAHEMVPPDVTISTHCHDDLGLSLANALAGVQAGAGEVQATLGGIGERCGNTPLEELAAVLVFKSAQVGAYTDLRIDQLYAAYVDLVDTTGMAVPRNKAIVGLNAFATQAGIHQDGILKNPATYEFMDPARWGRHRSILVGRHSGRAVVRYVLAELGAPEDDALVDRMYEELVASRPGSDCDELDHLRDEVALRLAVSP	MPNDWIPTSHENCSLVPGPFYHGTKAKLAIGDLLSPGHPSHFEQGRRLKHIYFAALMEPAIWGAELAMSLSRQEGRGYIYIVEPLGPFEDDPNLTNKKFPGNPTKSYRTSESLRIVEVVEDWQGHSPDVLQGMLASLEDLQRRGLAIIED	262.00	gnl|BL_ORD_ID|679|hsp_num:0	736			165	273	rifampin; rifaximin; rifabutin; rifapentine
BGC0000240.1|Lomaiviticin_5 # 4129 # 5898 # -1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.686	BGC0000240.1|Lomaiviticin_5 	4129	5898	-	Loose	1190	733.406	novA	64.51	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGACCACCACCGCCCCTGATGTGCCGGTACGGCGCATCCTCCGGTTGTTCCGCCCATATGGATGGAGCCTGGTAATCGTCGCCGGCCTGGTCGGCCTCTCGTCCCTGTTCTTCCTGGTCAACCCGTTCCTGATCCGAGAGATCCTGGACGTGGCCCTACCGGAGGGCCGGACGGGCCTACTCACCGTCCTCGCCGGTTGCATGCTCCTCGCGTCCGTCGCGAACAGCTCGGTCGTCGTCTGGCAGACCTACCTCTCCACGAAGGTCGGCGAGCAGGTGATGCACGATCTGCGCGCCGCCGTCTACGGACGCCTGCAGCGGATGCCGCTGGCCTTCTTCAGCCGGACCCGCTCCGGCGAGGTGCAGTCGCGGATCACCAACGACATCGGCGACATGCAGGCGACCGTGACCACCACCGCGACGACGCTGGTCTCCGACGTGACCGTGGTCGTGGCCACGGTCGTCGGGATGTTGGTGTTGGATTGGCGTCTCACCATCGTGTCGCTGGTGCTGGTGCCGTTCTTCGTCTGGGTCGGGCGACGGGTCGGCAACCAGCGCCGCCGCATCACCCGCGAGCGGCAACGCCAGGCCGCCGCGATCGCCGTGATCGTGCAGGAATCGCTCTCTGTCAGCGGTGTGCTGCTGGCCCGGACGATGGGCCGCTCCCGCTCGCTGACCGACATCTTCACCGCCGAATCGCGGATCCTGTCCGACCTGGAGATCCGCTCACACCTGGCCGGCCGCTGGACCCAGGCGACAACCTGGATCGTGTTGGCGTCGATGCCGGCGGCAACGTATTGGGTGGCGGGAATGAACGGCCGCGGTGGTCAGGCGGCGATCTCCATCGGCACCCTGGTCGCCTTCACCACCCTGCAGCAGACGCTGCTGCGACCGGCGGTCTCCCTGGTGGAGGTCGCCGTGGAGGTGCAGACCTCACTCGTCCTGTTCGGCCGGATCTTCGAGTACCTCGACCTGCCCGTCGACCTCGACGAGTCGGCGGGTCCCGCCCCCGGCACGAAGCCGCGGGGGGAACTCCGGCTCCAACAGGTCGGCTTCACCTATCCGGGCGCGGACCGGCCCACGCTGCGCGACATTGACGTGACGGTCCCCGCCGGCCGGAGCCTGGCGATCGTCGGTGAGACCGGGTCCGGTAAGACCACCCTCAGCTATCTGATCCCGCGGCTGTACGACCCGACGTCGGGACGGGTGACAATCGACGGTACCGATGTGCGGGACCTGCCCGCGGAGACGCTGGCGGCCACGGTCGGCATGGTGTTCCAGGAAACCTACCTGTTCCACACCTCGGTCGCCGAGAACCTGCGGTTCGCCCGGCCCGACGCGACCGACGACGAGTTGGTGGCGGCCGCCAGGATCGCCCATATCCACGACCACCTGCTGTCGCTGCCGCACGGGTACCACACCGTGGTGGGCGAACGGGGATTCCGGTTTTCCGGCGGGGAACGGCAGCGCCTGGCGATCGCCCGGGCGGTCCTACGCGATCCGCCTATCCTGGTGCTCGACGAGGCGACCAGTTCCCTGGACAACCAGACCGAAGAGGCCGTCACCCGGGCCATCGATGCAGCCAGCGCCGGTCGCACCACGATCACGATCGCGCACCGGCTGTCGACGATCCGCGACGCGGACGAGATCATCGTGCTGGATGCCGGCACCATCGTCGAACGCGGCACCCACGCCGAGCTGGTGGAGTTGGGGGGGCACTACGCGATGCTCGTCAACCGCGAGGCCGAGGTGCCGGCAGACGCCCGCTAG	MTTTAPDVPVRRILRLFRPYGWSLVIVAGLVGLSSLFFLVNPFLIREILDVALPEGRTGLLTVLAGCMLLASVANSSVVVWQTYLSTKVGEQVMHDLRAAVYGRLQRMPLAFFSRTRSGEVQSRITNDIGDMQATVTTTATTLVSDVTVVVATVVGMLVLDWRLTIVSLVLVPFFVWVGRRVGNQRRRITRERQRQAAAIAVIVQESLSVSGVLLARTMGRSRSLTDIFTAESRILSDLEIRSHLAGRWTQATTWIVLASMPAATYWVAGMNGRGGQAAISIGTLVAFTTLQQTLLRPAVSLVEVAVEVQTSLVLFGRIFEYLDLPVDLDESAGPAPGTKPRGELRLQQVGFTYPGADRPTLRDIDVTVPAGRSLAIVGETGSGKTTLSYLIPRLYDPTSGRVTIDGTDVRDLPAETLAATVGMVFQETYLFHTSVAENLRFARPDATDDELVAAARIAHIHDHLLSLPHGYHTVVGERGFRFSGGERQRLAIARAVLRDPPILVLDEATSSLDNQTEEAVTRAIDAASAGRTTITIAHRLSTIRDADEIIVLDAGTIVERGTHAELVELGGHYAMLVNREAEVPADAR	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	95.77	gnl|BL_ORD_ID|1112|hsp_num:0	1210			75	1791	novobiocin
BGC0000240.1|Lomaiviticin_6 # 5995 # 6315 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=6bp;gc_cont=0.685	BGC0000240.1|Lomaiviticin_6 	5995	6315	-	Loose	560	24.6386	OXA-302	30.56	3001757	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGACTTCGTCAAGGTGTGCCCGGTGACGGCGCTCCCAACCGAGGGCGCGATCGAGGTAAAGGTCGAGGGCCGAGCGGTGGCTGTGGTCCGGAGTGGGGGACGGGTATACGCGATCGACGACCGGTGTTCCCACGCGGAGGTTTCACTCGCCGAGGGAGAGGTGTACGACGGCACGATCGAGTGCTGGCTACACGGCTCCTGCTTCGACCTGCGCACCGGCGAGCCGACCAATCCCCCAGCCACCCGACCGGTCGGCACCTACCAGGTACGGGTCGAGGACGGGGACGTCTACGTCGCCCCCGGCGGAGCCCAGCCCTGA	MDFVKVCPVTALPTEGAIEVKVEGRAVAVVRSGGRVYAIDDRCSHAEVSLAEGEVYDGTIECWLHGSCFDLRTGEPTNPPATRPVGTYQVRVEDGDVYVAPGGAQP	MMMSKKLKCLALLTPCILILQLTACQSVSQQKQQLSTQTNEQQQISSLFQSAQTKGVLVIYDGKKIQSYGNDLNRAEQRYIPASTFKILNALIGIQYHKTTPNEVFKWDGKKRTFSSWEKDLSLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLQITPVEEVRFVYALAKQKLPFDQSTQQQVKGMLLADERQGTKIYAKSGWGMDVSPQVGWWTGWIEQPNGKTIAFSLNMQMSQPEHANARKVIVYQALQELGLLAN	37.86	gnl|BL_ORD_ID|2392|hsp_num:0	3464			552	660	cloxacillin; oxacillin; cefalotin
BGC0000240.1|Lomaiviticin_7 # 6569 # 6979 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.650	BGC0000240.1|Lomaiviticin_7 	6569	6979	+	Loose	200	26.5646	FosK	32.91	3003207	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGAACATCACCATCCACTCGAGCTTTCTGCCGCACGAGAATGCGGACGCGTCGATCACCTTCTACCGGGAAGTCCTGGGCTTCGAGATTCGAAACGATGTCGGTTACGAGGGGATGCGGTGGGTCACGGTTGGCCCGGTCGGCCAGCCGCAGACCTCAATCGTGCTCCAACCACCGGCGGCCGACCCCGGGATCACCGACGGTGAGCGGCGCACGATCGAGGAGATGATGGCGAAGGGCACCTACGCTGGTGTTCTCCTCGCCGCCCCCAACCTCGACGAGGTGTTCGAGCGGGTACAGGCCAGCGGAGCCGAGGTGGTGCAGGAGCCGATTGATCAGGACTACGGGGTCCGGGACTGTGCCTTCCGGGACCCGGCCGGCAACCTGATCCGGATCCAGCAGGCGGGTTGA	MNITIHSSFLPHENADASITFYREVLGFEIRNDVGYEGMRWVTVGPVGQPQTSIVLQPPAADPGITDGERRTIEEMMAKGTYAGVLLAAPNLDEVFERVQASGAEVVQEPIDQDYGVRDCAFRDPAGNLIRIQQAG	MITGINHITFSVRDLSSSIEFYRDLLGMRLHVTWEAGAYFTAGDTWVCLSVGEPKPANDYTHVAFSVGERELVELHARLKEAGVEEWKQNTSEGNSVYLLDPNGHRIELHCGTLATRLAELEKSPYKRLVWC	103.03	gnl|BL_ORD_ID|1564|hsp_num:0	1703			45	252	fosfomycin
BGC0000240.1|Lomaiviticin_8 # 7155 # 7844 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.683	BGC0000240.1|Lomaiviticin_8 	7155	7844	+	Loose	200	26.5646	BRP(MBL)	35.42	3001205	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic inactivation	Bleomycin resistant protein	GTGGAGTTGGATCTGCACGGCGTGGCCCGGCTCGCCGTGTGCCCGATTGCGAAGCTGGCGGCGCAGGCGCAGGCGCAGCCCGTAGCACCGAGCTATCGCGGCTACGTCCTCAGCTATGTCGTCAACCAGCCCGACGAGGTGCGAAGCATCCTGGATGCGGCCGCCCGGCACGGCGCGAGCGTTCTCAAACCGGCGAAGAAGGCCATGTTCGCCGGTTTCTCCGGCGCCTTCCAGGCTCCGGACGGTGCGGTGTGGAAGCTGACCTCGGCGAAGGCGAAGGCGACCGGGCCCGCGCAGGAGACGCCGGTGCCGAATGAGGTCGGTATTCTCCTCGGCGTCGCGGCGACGAAGTCCGCCAAATCCTTCTATGCGGCCCTGGGCATGGTGGTCGACCGGGACTACGGCAGCAAGTACATCGACTTCCAGCCAACTCCGACTGGCTGCCGGCTGGGCCTCATGGACGGAAAGGTACTGGCCAAGGACGTCGCCACCAAGGAGGACCGCGCCGACTTCCGGGCAGCGGCCCTCGAACGGATGCTGCCCTCGCCGGACGAGGTCGACTCCCTCCTGTCGACGGTGACCGCTGCCGGCGGCCGGGTCGTCGCCCCGGCTGCGAAATCCGGGTCGGGAGTCTACGCCGGCTACTTCACCGATCCGGACGGCTTTCTGTGGAAGGTGACCTCCGGGTAG	MELDLHGVARLAVCPIAKLAAQAQAQPVAPSYRGYVLSYVVNQPDEVRSILDAAARHGASVLKPAKKAMFAGFSGAFQAPDGAVWKLTSAKAKATGPAQETPVPNEVGILLGVAATKSAKSFYAALGMVVDRDYGSKYIDFQPTPTGCRLGLMDGKVLAKDVATKEDRADFRAAALERMLPSPDEVDSLLSTVTAAGGRVVAPAAKSGSGVYAGYFTDPDGFLWKVTSG	MADHVTPNLPSRDFDVTEAFYAKLGFATSWKDRGWMILQRGGLQLEFFPYPDLDPATSSFGCCLRLDDLDAMVALVNAAGAEEKSTGWPRFKAPQLEASGLRIGYLIDPDCTLVRLIQNPD	189.26	gnl|BL_ORD_ID|2356|hsp_num:0	255			198	339	bleomycin; bleomycinic acid; bleomycin A2; bleomycin B2
BGC0000240.1|Lomaiviticin_9 # 7929 # 9491 # -1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.686	BGC0000240.1|Lomaiviticin_9 	7929	9491	-	Loose	400	27.335	ANA-1	30.0	3006896	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ANA beta-lactamase	GTGAAAAGACTCTTCGCTGGTGCGACCGCAGTCGTACTGGGCCTCACGGCACAGGTCATCGCCGTCGCCCCGGTCGGGGCGGCACCAACGGCGGGCAGCACCGCCCTGCCGGCCAGCCCAATCTCCTGGTCCCCCTGCCCCGCCGACGACCCGGTGATGGAGGATTACCTGGTCGGGCTGGATTGCGGCTCGCTCGCAGTGCCGCTTGACCACTCCCGACCGACCGGCCAGAAGATCACCCTGGCTCTCACCCGAGCCGAGCACACCGCGCCGGAATCCGAGTACCAGGGCGTTGTCCTGCTGAACCGGGGCCAGTGGCCCGGCACCATCGGACGGGACCTGCCCACCCGCTTCGCCAAAGGCTGGAGCGGGCTGCCGACCGAGGTGGGTTCGACCTACGACTGGATCGGGTTCGACCCCCGCGGCGTCGGAGCGAGTGAGCCGTCGATCACCTGCGACCCCACCTACCTTTATCCGGGTGAAGCACGGCCCGACTACGTTCCGGGCAGCCGCGCCGAGGAGAGGGCGTGGACGAAGCGGGCCCGCGCGTACGCGCAGAGCTGCGGCGAGAAGTACGGTGACACCCTCCGGCACTTCCGAACCACCGACACCGCGCGGGACATGGATCTCATCCGGGCCGCGCTCGGTCAAGAGAAGATCAACTATCTAGGCTACTCCTACGGCACCTACCTCGGCTCGGTCTACGCCTCCCTGTTCCCGGACCGGGTGCGCCGGATGGTACTGGACAGTGTGGTGCAGCCAAGCACAGTCGGGTATGCCTCGCTGTCCCGCACGAATGCGGCCTTCGAGCAGCGCGCACAGATCTACTTCAGCTGGATCGCCGAACACGACTCGCACTATCACCTTGGCGACACGGCCGCGGCGGTCGAGGCGAACTACTACCAGGGCATGGCCGCACTCCGGGAGGCGCCGATCGACGGCCAGATCGGCCCGGCGGAGTACAGCGACATCTTCGCGGTGAACGTGTACCGCAGCTACGTCTGGACCTACCACGCGCAGGTGCTGGCTGACTGGGTGCTGCGGGGTAACCCGGCCGGGCTGCGGGCGAACTTCGGCGGCGAGCCGGGCTTCCCGGCGCAGAACACCCACGCCACGTACCGCACCGTGCAGTGCGTCGACGGCTACTGGCCCCGGCGCTGGAACCGCTGGCACACCGACCTGAGCCGCCAGTACGACCGCGGAGACCGCTTCATGACCTGGAACAGCGCGTGGTACAACGCTCCGTGCGCGTTCTGGCCGGTGCCAGGCCGCCGGCCGACGCAGGTCGGCGACCGGAACGCGAACATACTGCTGATCCAGGCGGAACACGACGCACTCACCCCGGTGGCCGGGGCCCACGAGGTGCACCGGCGATTCCCGAACTCCCGGCTGGTCCTGGAGCGCGGCGGCGTCTTCCACGGCGCGTCCCTGACCGCCAACGCCAACGAGTGCCTCAACATCCACGTCACCGCCTACCTAAGAGACGGCACCCGTCCGAGCGCCACCACCGGCGTTGACGCCAGCTGCGACGCGAATCCGCTACCAGCTCCGGAAGCTGGCTGA	MKRLFAGATAVVLGLTAQVIAVAPVGAAPTAGSTALPASPISWSPCPADDPVMEDYLVGLDCGSLAVPLDHSRPTGQKITLALTRAEHTAPESEYQGVVLLNRGQWPGTIGRDLPTRFAKGWSGLPTEVGSTYDWIGFDPRGVGASEPSITCDPTYLYPGEARPDYVPGSRAEERAWTKRARAYAQSCGEKYGDTLRHFRTTDTARDMDLIRAALGQEKINYLGYSYGTYLGSVYASLFPDRVRRMVLDSVVQPSTVGYASLSRTNAAFEQRAQIYFSWIAEHDSHYHLGDTAAAVEANYYQGMAALREAPIDGQIGPAEYSDIFAVNVYRSYVWTYHAQVLADWVLRGNPAGLRANFGGEPGFPAQNTHATYRTVQCVDGYWPRRWNRWHTDLSRQYDRGDRFMTWNSAWYNAPCAFWPVPGRRPTQVGDRNANILLIQAEHDALTPVAGAHEVHRRFPNSRLVLERGGVFHGASLTANANECLNIHVTAYLRDGTRPSATTGVDASCDANPLPAPEAG	MRTLLARVVVLLLVPWSAARGEPETDLGDRVRARPLSAHAWLIRSVSALEGFGDVESNAVLVTGATESVLVDTPATDEQTAPVLAWAEKTLRRPVRHLIVTHWHADRMGGIGAARARQVATYAFGRTRALARQKGLVVPEHELGPAERLTLAGLSLATWYPGHGHTADNIVVWLPEDGVLVAGCFVKDAAAGTLGNVREADPVQWATGVAALRRRYPGARIVVPGHGAAGGSELLARTTALLEAHGSRGVPASGR	203.92	gnl|BL_ORD_ID|3293|hsp_num:0	4362			555	735	
BGC0000240.1|Lomaiviticin_10 # 9579 # 10700 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.710	BGC0000240.1|Lomaiviticin_10 	9579	10700	-	Loose	700	35.039	oleD	23.3	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGAGGTTTCTCTTCCTCACCACCGGCAGCCACGTCACTGTCTATGCGATGACCGCCCTGGCCCATGCGGTACGCAACGCGGGGCACGAGGTACTGGTGGCCACGAACGAGCCGCTCATCGACGCGGTGGAGACGGTCGGCCTACCCGGGGTGTCGATCACGTCGGCGTCGATCCGGCGCTTCCTCGCCACCGTCGACTCGCCGCACGAGATGGTGGTGACCGGCCGCGGACTGGGGAGGATGGCCGCCGCCACGCTGGCGGGCCTGAGCGAGCTGGCACAGGACTGGAGGCCGGACGTCATCGTCGGTAGCTCGATGAGCTACGCGGCAGGGTTGCTCGCCGCCGCACGGGACGTCCCCTTCGTACGACACATCGAGTATCTGCGCATTCCGATGGCGGAGATCGACCCGGTGGCGGCGGAGGAGCTTGCGCCGGAGCTGAGCCGCCGGGGTCTGGGCGGGCTACCCAAACCCGACCTGGTGGTTGATGTCAGCCCGCCGTCGCTGCGGTCGTCGCCCGCCGCCGACGTACACCCCATGCGCTACGTGGCCACGAACCCCCAGCGTCGCCTCCAACGGTGGGCCTACACCCGTCCGCCGGGCCGCTCCCGGGTGTTGATCACCTCCGGAACGCACCATCGCATGCTCGCCGGCCGTTCGTTACGGCGGCTGGCAGCGCAGCTCACCGCCGTGGGCGCCGAGGTGGTGATCGCGGCGCCCACTCGGGTCGCCGAGGAGTTCGGTGCGACGGCGGAGGACGTCCGCATCGGTTGGATCCCGTTGGACACCGTGGCACCCACCTGTGACCTGGCGGTCCACCACGGCGGCGCCACCACCACGATGGCCGTCATCGCCGCGGGAGTGCCGCAGGTAATCACTCCCCCGAACACGCACACCAGGGCGATCGCCGACGCTCTGTCCAACTTCGGCGCCGCCGTGACGGCCCGCGCTCCCCACCAGGCCGACCACGAGCTGGCGGACGTACTGGCCGCCCACAGCCGAGAGCTACTCGCCGACCACCGGTACGCCCGGCAGGCGCAGGCCCTCGCCGCCGAGCTGGCCGCACTGCCCACCCCGGCCGACGTCGTCCGGAGGATGGAAACGCTGACCGCCACCCGATGA	MRFLFLTTGSHVTVYAMTALAHAVRNAGHEVLVATNEPLIDAVETVGLPGVSITSASIRRFLATVDSPHEMVVTGRGLGRMAAATLAGLSELAQDWRPDVIVGSSMSYAAGLLAAARDVPFVRHIEYLRIPMAEIDPVAAEELAPELSRRGLGGLPKPDLVVDVSPPSLRSSPAADVHPMRYVATNPQRRLQRWAYTRPPGRSRVLITSGTHHRMLAGRSLRRLAAQLTAVGAEVVIAAPTRVAEEFGATAEDVRIGWIPLDTVAPTCDLAVHHGGATTTMAVIAAGVPQVITPPNTHTRAIADALSNFGAAVTARAPHQADHELADVLAAHSRELLADHRYARQAQALAAELAALPTPADVVRRMETLTATR	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	89.88	gnl|BL_ORD_ID|1253|hsp_num:0	1367			630	1146	erythromycin; tylosin
BGC0000240.1|Lomaiviticin_11 # 10697 # 11656 # -1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.733	BGC0000240.1|Lomaiviticin_11 	10697	11656	-	Loose	500	35.4242	chrB	39.19	3001302	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	GTGGTGGTAACCCTGGGCGTGGCCGAGCAGCTGGCGGCTGGCGTCACCGAGATCGGAGAGCTTGCCCGCCACACCGAGTGTGACCGGGACTGCCTGGCCCGGGTCCTGCGCCACCTGGTCGGCAAGGGCGTCTTCGAAGAGCCGGTCGAGGGCGAGTTCGCCCTGAACGAGGCGGCCCGTTCCCTGCTGAGGTCCGGCCGGCTGCACGGCCTGGCCCTGGACGGCCACGGTGGACGCAGCGCCGCCGCCTGGAGCGGACTGCTGGCGACGGTGCGGACCGGACAACCCGGGTACCAGACCGTCTTCGGACGCTCCTACTGGGCCGACCTCGACGCCGACGCCGACCTCTCGGCCAGCTACGACGCGAACATGGGTCGGCACGCCGGCGAGGCATCCGATCCGGCGGTCCTCCTCGACGACGCCTGGACTCAGGTCGGTCACGTCGTTGACGTGGGCGGTGGGACCGGCGAGACGCTCGCCGAAATCCTGCGGGCCCGACCGACGGTCCGCGGCACCCTGATTGACCTACCCCGAACGGTCGCCCGGTCCACCGAGGTCTTCGCGGCCGCGGGGGTTGCCGACCGGGTCGCCGTACAGGGGCAGAGCTTCTTCGACCCGCTGCCCGCCGGAGCCGACGTCTACCTGCTCAAACGCCTGCTCCTGGACTGGCCGGACGAGCAGGCCGTCGCGCTGCTCACCCGCTGCGCCGAGGCCGCGGCACCGGACGGCCGCGTGGTCGTGGTCGGCGGGGTCTCCCCGGGGCGGTCGGCCGCCTCGGCCGGGCTACTGATGATGGTGCAGACCGGCGGCAAGCCCCGGACCCTGGACGAGTTCCGGGACCTCGCCGCGCGCGCCGGCCTCGCCGTGACGGCATCCGGGCACAGTCCGTCGGGTCAGTTCGTCACCGAATGCCGCCTCGCGGCGGGCAGCACCGCACGGAAGACCAACGCCCGCCGATGA	MVVTLGVAEQLAAGVTEIGELARHTECDRDCLARVLRHLVGKGVFEEPVEGEFALNEAARSLLRSGRLHGLALDGHGGRSAAAWSGLLATVRTGQPGYQTVFGRSYWADLDADADLSASYDANMGRHAGEASDPAVLLDDAWTQVGHVVDVGGGTGETLAEILRARPTVRGTLIDLPRTVARSTEVFAAAGVADRVAVQGQSFFDPLPAGADVYLLKRLLLDWPDEQAVALLTRCAEAAAPDGRVVVVGGVSPGRSAASAGLLMMVQTGGKPRTLDEFRDLAARAGLAVTASGHSPSGQFVTECRLAAGSTARKTNARR	MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA	113.93	gnl|BL_ORD_ID|274|hsp_num:0	305			183	381	tylosin; chalcomycin; mycinamicin
BGC0000240.1|Lomaiviticin_12 # 11996 # 12922 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.648	BGC0000240.1|Lomaiviticin_12 	11996	12922	+	Loose	400	29.261	VIM-59	28.74	3005507	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	VIM beta-lactamase	ATGACAGGCGTATACCGAGCGAGCCGACAGTGGGAACGCATCACTCGGCACTGGTTCACCGAGGACGCGGCAGTAGATCTCTCGCACTTCAAGTCGGAGCGGCCGAACCACAAGATGTCGTTGTGGGATCCTGAGGTGAACGGCGTGCGGTATCTCAAAACGCTGGTACACAATCTGGCGACCACACTTGATCCGGACGACTGGGCGCGGTTGCGTCGGACGGCCCGGCGTGAGGTGGGTGATCCGGTCGTGGTGCGGTGGCACGGAATGCCGATCTGCCTGGACTACCTGCAGGCCACGCTCGAGGTCGGGTTCATCGAGCGGAGCATCGACCTACGGGGCGCCCGGGTGCTCGAGATCGGAGCCGGCTACGGGCGGACCTGTCACACCCTGCTGTCAAACTATGATGTCGCTGCCTACTACATTGTGGATCTGCGCAGTACCATGCGGTTCAGCCGTCGCTATCTGCGGGTGGTCCTGGACGATGCCCAGTTCGCGAAGCTCCGCTTCGTCCCGGTGGAGGACGGGGACGTGGGACTGGCCCTCAGCGGAAGCGATTTCGACCTCGGCATCAACATCAACTCGTTCGCCGAAATGACCCCGGAGACCGTACGCTGCTACCTCGATCTGATCGACCGGCGGTGCGCGGCCCTGTATGTGAAGAACCCCGTCGGCAAGTACCAGGATCGGAGCCTGGACGGACACGTCGAGGGCGACGAGGCCCGATGGCGGGCGATGGAGACCGGTCCACTCCGCCAGGTTCTGGATATCCACGACAACCAGGCGGTGCGGGCCGCCGTGCCGGGGTTCCTCGCGGCCTATCGGCCCGGCCCCGACTGGCGCGATGTCAATGATGCGTGGGCCGTGCCGTGGAGCTTCTACTGGCAGGCCGTCTACCGCCGGAAACGACCGGGCGGTGGCGGCTGA	MTGVYRASRQWERITRHWFTEDAAVDLSHFKSERPNHKMSLWDPEVNGVRYLKTLVHNLATTLDPDDWARLRRTARREVGDPVVVRWHGMPICLDYLQATLEVGFIERSIDLRGARVLEIGAGYGRTCHTLLSNYDVAAYYIVDLRSTMRFSRRYLRVVLDDAQFAKLRFVPVEDGDVGLALSGSDFDLGININSFAEMTPETVRCYLDLIDRRCAALYVKNPVGKYQDRSLDGHVEGDEARWRAMETGPLRQVLDIHDNQAVRAAVPGFLAAYRPGPDWRDVNDAWAVPWSFYWQAVYRRKRPGGGG	MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQSFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKRYPEAEVVIPGHGLPGGLDLLQHTANVVKAHKNRSVAE	115.79	gnl|BL_ORD_ID|4637|hsp_num:0	5708			507	765	
BGC0000240.1|Lomaiviticin_13 # 12865 # 13992 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.715	BGC0000240.1|Lomaiviticin_13 	12865	13992	+	Loose	700	33.8834	vanS gene in vanA cluster	29.03	3002931	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	GTGGAGCTTCTACTGGCAGGCCGTCTACCGCCGGAAACGACCGGGCGGTGGCGGCTGACCAGCCGGACCGGCGACGAAGCCGGAGGGTACGACAACTCGCGAACACCGGAGATCGGAGGAGCGGTGGACCGGGAGCCGGCGACGGGCGGTGACCCACCCCTGGTGAGCGTACTGGGAGCGGCTGGCTATCTGGGGTCGGTCGTCACCGCCCGGTTGGCGCAGCTTCCGATCCGGTTGCGGGCCGCCTCGCGTCGCCGTAGCCCGCTACCGGAGCAGGTGGTGGCCGAGGTGGAGGTCTGCACCGGGGACCTCACCGAGACAGAGCGCCTGGCCGATGTCGTCGCGGGCGCCGACGTCATCCTGCACCTGGGTAAACACAGCGGTGGGTGGCGTGACGCCGACACTCCGGAGGGAGAACGGGTGAACGTGGGCATCGTGCGTGACCTCATCGAGATTCTCGGCCGGCGCCGGCCGACGCGGACCACTCCGTTGGTGGTGCTCGCCGCGACCACCCTGCAGGTGGGACAGCCCCCGAAGCGGCCGATGACCGGCAGCGAACCGGACCGTCCGGAGACCGCCTACGGCCGGCAGAAGCTGACCGCCGAACGGTTGCTGAAGGCCGCGAGCGCGGCGTCGGTACTGCGTGGGGTCAGCCTGCGGCTGCCGACCGTGTTCGGGCAGAGCCCACTGTCCCCGGTGGCTGATCAGGGCGTGGTGGTCACGATGGCCCGGCGGGCCCTCGCCGGTCAGCCGCTGACGATGTGGCATGACGGCACCGTTCGGCGGGACCTGGTGTATGTCGAGGATGCCGCGGACGCCTTCCTGGCCGCCATGCGCTGCCCGGATGCGCTGACCGGTCGACACTGGCTGGTGGGCTCCGGCCGCCCGGACACGCTGGGCGCGGTCTTCCGCACGGTGGCGAGGTCGGTCGCGGCGCAGACCGGCGAGTCGGCCGTACCGGTGATCTCGGTACCGGCGCCGGCCGACGTCCCCGTGATCGACTTTCAGAGTATGCAGATCGACCCGACGCCCTTCCAGCGTGTCTCGGGGTGGTGTGCGCGCACGGAGCTCGCGGAGGCGGTGCACCGCACCGTGGCGGCCCTGCTCGACGGGCGTGACCGGTTCTAG	MELLLAGRLPPETTGRWRLTSRTGDEAGGYDNSRTPEIGGAVDREPATGGDPPLVSVLGAAGYLGSVVTARLAQLPIRLRAASRRRSPLPEQVVAEVEVCTGDLTETERLADVVAGADVILHLGKHSGGWRDADTPEGERVNVGIVRDLIEILGRRRPTRTTPLVVLAATTLQVGQPPKRPMTGSEPDRPETAYGRQKLTAERLLKAASAASVLRGVSLRLPTVFGQSPLSPVADQGVVVTMARRALAGQPLTMWHDGTVRRDLVYVEDAADAFLAAMRCPDALTGRHWLVGSGRPDTLGAVFRTVARSVAAQTGESAVPVISVPAPADVPVIDFQSMQIDPTPFQRVSGWCARTELAEAVHRTVAALLDGRDRF	MVIKLKNKKNDYSKLERKLYMYIVAIVVVAIVFVLYIRSMIRGKLGDWILSILENKYDLNHLDAMKLYQYSIRNNIDIFIYVAIVISILILCRVMLSKFAKYFDEINTGIDVLIQNEDKQIELSAEMDVMEQKLNTLKRTLEKREQDAKLAEQRKNDVVMYLAHDIKTPLTSIIGYLSLLDEAPDMPVDQKAKYVHITLDKAYRLEQLIDEFFEITRYNLQTITLTKTHIDLYYMLVQMTDEFYPQLSAHGKQAVIHAPEDLTVSGDPDKLARVFNNILKNAAAYSEDNSIIDITAGLSGDVVSIEFKNTGSIPKDKLAAIFEKFYRLDNARSSDTGGAGLGLAIAKEIIVQHGGQIYAESNDNYTTFRVELPAMPDLVDKRRS	97.66	gnl|BL_ORD_ID|1809|hsp_num:0	1907			759	927	vancomycin; teicoplanin
BGC0000240.1|Lomaiviticin_14 # 14002 # 14613 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.678	BGC0000240.1|Lomaiviticin_14 	14002	14613	+	Loose	200	25.7942	vanH gene in vanA cluster	30.16	3002942	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	GTGAAGGTCGAGAAGCTCACGGTCCAGGGCGCGTTCGTGTTTACCCCCGAGGTCTTTCCCGACCGCCGTGGACTGTTCGTGTCACCGTTCCAGCGAGCACCGTTCGCTGCGGCGAGCGGGAGCCCGCTCCTGCCCGTCGCGCAGACCAACCACAGCGTGTCCCACCGGGGTGTGGTCCGCGGAGTCCACTACACCAGCGCGCCGCCGGGTGCGGCGAAGTACGTCTACTGTGCTGCCGGTACGGCGATCGACATCGTCGTGGACGTCCGCGTCGGTTCACCGACGTTCGGCCGCTGGGACGCGGTGCGGATGAGCTCGCGGGAGATCCGGGCGATGTACTTTCCGGTCGGGGTCGGGCACGCCTTCGTGTCGCTCGCCGACGACACCGTCATGTCCTACATGCTCACCGGGTCGTATGTCCCGGAGCATGAGCGGGTGGTCTCCGCCCTCGACCCAGCTCTGGGGCTGCCGATCCCCACGGACCTGGAAACGATCATCTCTGACCGGGACCGGGGGAGTCCGAGTCTGGCCGAGACCGCCGAGGCCGGCCTGCTCCCCGACTACCAGCTGTGCCAGGTGCTGGAGCAGCAGCTATATCAGGTGGCCCACTGA	MKVEKLTVQGAFVFTPEVFPDRRGLFVSPFQRAPFAAASGSPLLPVAQTNHSVSHRGVVRGVHYTSAPPGAAKYVYCAAGTAIDIVVDVRVGSPTFGRWDAVRMSSREIRAMYFPVGVGHAFVSLADDTVMSYMLTGSYVPEHERVVSALDPALGLPIPTDLETIISDRDRGSPSLAETAEAGLLPDYQLCQVLEQQLYQVAH	MNNIGITVYGCEQDEADAFHALSPRFGVMATIINANVSESNAKSAPFNQCISVGHKSEISASILLALKRAGVKYISTRSIGCNHIDTTAAKRMGITVDNVAYSPDSVADYTMMLILMAVRNVKSIVRSVEKHDFRLDSDRGKVLSDMTVGVVGTGQIGKAVIERLRGFGCKVLAYSRSRSIEVNYVPFDELLQNSDIVTLHVPLNTDTHYIISHEQIQRMKQGAFLINTGRGPLVDTYELVKALENGKLGGAALDVLEGEEEFFYSDCTQKPIDNQFLLKLQRMPNVIITPHTAYYTEQALRDTVEKTIKNCLDFERRQEHE	63.04	gnl|BL_ORD_ID|4669|hsp_num:0	178			549	738	vancomycin; teicoplanin
BGC0000240.1|Lomaiviticin_15 # 14662 # 15666 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.693	BGC0000240.1|Lomaiviticin_15 	14662	15666	+	Loose	200	27.7202	vanH gene in vanA cluster	44.44	3002942	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGCCCGCTCTCATCCGGCTGGGAGTCCTGGGGTGTGCCAGCATCGCGCTCCGCCGGTTTCTGCCGGCCTTGACCGAAGCGACCGGGATCGAACTGAGAGCGGTCGCGAGCCGCGACCCCGCCCGGGCCGGTACGGTCGCCGAGCAGTTCGGCTGCCGGGCTGTCGACGGGTACGACGAGTTGCTGGACCGGGCCGACATTGACGCGGTATACATTCCACTGCCCACCGGGCTGCACGCGTACTGGGTGAGCCGGGCCCTGGCGGCCGGCAAGCACGTGCTCTCCGAAAAGCCGCTCACCAGTGACCAGGTCACCGCCCGCAAGCTGGTGAACCAGGCGGAGCAGGCGGGACTCTGGCTACTGGAGAACTACATGTTTCTCCACCACCGTCAGCACGAGATGGTCCGCGATCTTGTCGCCGCGGGCCGGATCGGCACGACCCGGCTCTTCACCGCACGATTCGGCATCCCGCCACTCGCCCCGACGAACTGGCGCTACCGCGGCGAGTTCGGCGGGGGCGCGCTGCTCGACGTCGGCGTCTATCCGCTGCGCGCCGCCACCTACTTCCTCGGCCCGGAGCTCGACGTCGTCGGCTCGGTGCTGCGGACGAGTCCGGGCCGCGGCGTTGACCTGGCCGGCCACGTCCTGCTGGCGACCCCGTCGGGGGTGACGGCAGAACTCTCCTTCGGGTTCGAGCACGCGTACCGATCCTGTTATTCGCTCTGGGGGGAACGGGCGCGACTCACCCTGGACCGGGCTTTCACTCCGCCGGTCACCCGACAGCCGGTGATCCGGATCGAGGCTGACGGCCATCCCGAGGAGGTGCGGCTCCCCGCAGATCATCAGTTCCGGAACATCGCGGAGTTCTTCGCCCGGTCCGTGCTCGATGATGCGGACTACCGTCCGCAGGCGAGGGCGATCAACCAGCAGGCGGAACTGATCGACAAGGTGCGGTCGTCCGCCGTGCGCCTCCCCTCGTCGCACGGGGACGCACGGAGCGGGTGA	MPALIRLGVLGCASIALRRFLPALTEATGIELRAVASRDPARAGTVAEQFGCRAVDGYDELLDRADIDAVYIPLPTGLHAYWVSRALAAGKHVLSEKPLTSDQVTARKLVNQAEQAGLWLLENYMFLHHRQHEMVRDLVAAGRIGTTRLFTARFGIPPLAPTNWRYRGEFGGGALLDVGVYPLRAATYFLGPELDVVGSVLRTSPGRGVDLAGHVLLATPSGVTAELSFGFEHAYRSCYSLWGERARLTLDRAFTPPVTRQPVIRIEADGHPEEVRLPADHQFRNIAEFFARSVLDDADYRPQARAINQQAELIDKVRSSAVRLPSSHGDARSG	MNNIGITVYGCEQDEADAFHALSPRFGVMATIINANVSESNAKSAPFNQCISVGHKSEISASILLALKRAGVKYISTRSIGCNHIDTTAAKRMGITVDNVAYSPDSVADYTMMLILMAVRNVKSIVRSVEKHDFRLDSDRGKVLSDMTVGVVGTGQIGKAVIERLRGFGCKVLAYSRSRSIEVNYVPFDELLQNSDIVTLHVPLNTDTHYIISHEQIQRMKQGAFLINTGRGPLVDTYELVKALENGKLGGAALDVLEGEEEFFYSDCTQKPIDNQFLLKLQRMPNVIITPHTAYYTEQALRDTVEKTIKNCLDFERRQEHE	103.73	gnl|BL_ORD_ID|4669|hsp_num:0	178			561	639	vancomycin; teicoplanin
BGC0000240.1|Lomaiviticin_16 # 15695 # 16336 # -1 # ID=1_16;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.690	BGC0000240.1|Lomaiviticin_16 	15695	16336	-	Loose	1700	25.7942	AxyY	58.82	3004144	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGGGCGACGCGGCCACACTGGCGCGGGAGATCCTGACCCTGAGCCCTGATCACGAGCTCGGCTGCATCGTCATGGGCAGCGGCTTCTCCCAGCGCGACGGCATCAACGAGGGCGAGTTCACGAAGCGGTTCTTCCTGGCGAACCTCGCCCGGCTCGAGGAGTTCCCCCGGCTGCGCCCGCTCCTGGCCCGGCTCGCCGGCCCGCAACGGGCCGCCTTCCGGCAGGCGCTACGGGACATCATCATCATGCCGCAGGCCGGCAACACGGTCGCCGAGTTGGAGACCGCGGCGGGCATCTTCGCCGCGCACGGCGTGCACCGGGTGCTGCAGGTAACTGCCGCCAGCCATGCTCCCCGCTGCCTCAAGGAGCAGACCGTCGCTCGGGCGTACGGTCTGATCGCGACGGAACAGCAGTGGTACACGGTCGCCACCGACATGGCCTACTGGGGCACCCACCCCGAGGATGTCTGCGTCATCGAGCCGCTCCACCGGCGCGACCAGCCGATGACGTTCGTACGGCCCGGGCTCTCCGAGGTCATCGCGCCGTACTTCTTCCTTCCGGATACCGACAAGAAGGCGTTCGTGGCGATGGTCGCGGAGTTCATGTCCGCCCGCGGCAGCACTGCCCAACCACCGCGATAG	MGDAATLAREILTLSPDHELGCIVMGSGFSQRDGINEGEFTKRFFLANLARLEEFPRLRPLLARLAGPQRAAFRQALRDIIIMPQAGNTVAELETAAGIFAAHGVHRVLQVTAASHAPRCLKEQTVARAYGLIATEQQWYTVATDMAYWGTHPEDVCVIEPLHRRDQPMTFVRPGLSEVIAPYFFLPDTDKKAFVAMVAEFMSARGSTAQPPR	MARFFIDRPVFAWVISLLIALVGLLSIRALPVAQYPDIAPPVVNIGASYPGASAKVVEEAVTAIIEREMNGAPGLMYTSSSSDSTGWASINLTFKQGTNPDIAAVEVQNRLKAVEPRLPESVRRDGVRVEKAADNIQLVVSLKSDGSLDDMQLGELAASNVLQALRRVEGVGKVQSFGAEAAMRIWPDPAKLTALSLTPGDIVSALRSHNARVTIGELGNQAVPKDAPLNASIVAGESLHTPEQFANIPLRALPDGATLRLKDVARVELGGTDYMYLSRVNGLTGTGLGIKLAPGSNAVETTRRIRETMRELAQYFPPGVTWDIPYETSTFVEISIKKVLMTLLEAVALVFCVMYLFMQNLRATLIPTLVVPVALLGTLGVMLGLGYSINVLTMFGMVLAIGILVDDAIVVVENVERIMAEEGLSPHDATVKAMGQISGAIVGITVVLVSVFVPMAFFDGAVGNIYRQFAVTLAVSIAFSAFLALSLTPALCASLLKPVPAGHHEKRGFFGWFNRAFARLTTRYTARVAGVLARPVRFGLAYALVIGVAALLFARLPSSFLPDEDQGSFMAMVILPQGSPQAETMAVVKDVERYMMEHEPVQYVYSVNGFSQYGSGPNSAMFFVTLKDWKERRDASQHVDAVVKRINKAFADRKNLMVFALNSPPLPDLGSTSGFDFRLQDRGGLGYEALTQARQKLLAKAAEHPALTDVVFAGQEEAPQLQLRVDRDKAQAMGVPIDEINTALAVMYGSDYIGDFMLNGQVRRVMVQADGKRRVDVDDISRLHVRNLQGQMVPLSAFATLTWSMGPPQLNRYNGFPSFTINGSAARGHSSGEAMRAMETLAAELPRGIGFDWSGQSYEERLSGNQAPVLFALSVLIVFLALAALYESWSIPLAVILVVPLGVIGALLGVTVRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVRDGQGILSATLEAARLRLRPIVMTSLAFGVGVLPLALATGAASGAQAAIGTGVLGGIITATVLAVFLVPLFFLIVGRMVGMRARPARPDGREPLETTP	20.38	gnl|BL_ORD_ID|2411|hsp_num:0	2799			1668	1719	erythromycin; cefepime
BGC0000240.1|Lomaiviticin_17 # 16545 # 17585 # -1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.720	BGC0000240.1|Lomaiviticin_17 	16545	17585	-	Loose	700	30.4166	oleD	28.57	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGAAGTTCATGTTCACCGTCGGGGGTAGTCAGTCCACCGTGTTCTGTATCGCCCCACTGGCGACCGCGGCCCGTAACGCCGGTCACGAAATCCTGCTGACCGCCGACGAACCGCTGCTGGAGACCGCGGCGGCGATCGGGTTGCCGGCGGTCCCCACGCCCCATCCGGGAAAGCCCGCGGCCCGGTTGCGGGCCCTGCTGGAGTTGGCGGGGCAGTGGCCACCCGATGTGGTGGTCGGTGGCCTGTCCTACGTCCCCGGCCTCGTCGCCGTGGAGACCCAGGCGCTGTACGTGCGCCACTACTGGGACATCGTGCCGCTGCGCCCAGAGCCGGGAATCACACCCGACCTGGAGCGACTTGGCCTGAGCGGGCCACCGGCGGCCGACCTGTTCATCGACGTGTGCCCGCCGGGCCTCCGGCCGTCGCCCACCCCCGGCGCACGGCCGATGCGCTGGATTCCGAAAAACCGGCAGGGTCGCCTGCAGCCATGGATGTACACCCGGCCCGCCGACCGCCCGCGGGTGCTGGTTACCGCGGGCACGCGCAACCTCTTCCTGCACTCGCGCAGCAGCGTCATCCGACATCTGGTGGACCAGCTCATCGCGGCTGGCGCCGAGGTGGTGATCGCGGCACCGGAACGCGCCGCCGCGGAGTTCGGCGCGCAGTTCCGCGATGTCCGCGTCGGCTGGGTACCGTTGGATGTCGTCGCCCCCACCTGTGATCTGGCGGTACACCACGGCGGCGCGGCTACCACGATGACGGTGCTGAACGCCGGCGCACCGCAGCTGGTGGTCCCCGACAACGACTACTCCCGGTCCGTCGCGAGGGCCCTCACCGACGTCGGCGCGGGCCTGACCGCCGCCCCGGTGCCCCCGGACGGCGACCGGGCGGCGGTCGAGGCGATCGCCGCCGGTTGCCGGCGAATCCTCGCCGACCCCCGGTACACCGATCGCGCACGGCTCCTGGCCGCCGAGATCGCCGGACTTCCCCCGCCCGCCGAGGTCGTGCACACGGTAGAGGAACTGGTCGCCAGCCGATAG	MKFMFTVGGSQSTVFCIAPLATAARNAGHEILLTADEPLLETAAAIGLPAVPTPHPGKPAARLRALLELAGQWPPDVVVGGLSYVPGLVAVETQALYVRHYWDIVPLRPEPGITPDLERLGLSGPPAADLFIDVCPPGLRPSPTPGARPMRWIPKNRQGRLQPWMYTRPADRPRVLVTAGTRNLFLHSRSSVIRHLVDQLIAAGAEVVIAAPERAAAEFGAQFRDVRVGWVPLDVVAPTCDLAVHHGGAATTMTVLNAGAPQLVVPDNDYSRSVARALTDVGAGLTAAPVPPDGDRAAVEAIAAGCRRILADPRYTDRARLLAAEIAGLPPPAEVVHTVEELVASR	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	83.37	gnl|BL_ORD_ID|1253|hsp_num:0	1367			825	1146	erythromycin; tylosin
BGC0000240.1|Lomaiviticin_18 # 17602 # 18813 # -1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.684	BGC0000240.1|Lomaiviticin_18 	17602	18813	-	Loose	1020	26.5646	tlrC	48.48	3002827	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	GTGAAAGACACGGTCGCCGATCTCGCCATTCTCGGCGGGACTCCGACGTTCCCGCAGATGCTGCAGGTGGGAACGCCCAGCGTGGGAGAGCGGTCGCGGTTGTTCGAGCGACTGCACACCGCGCTGGACAACAAGTGGCTCACCAATGGCGCCCTGGTCCGGGAGTTCGAGGAACGCATCGCGACGCTGGCAGGCGTACGGCACTGCGTGGCGACCTGCAGCGGCACCATGGCGCTGCAGCTGCTCTACCAGGCCACCGAGCTCACCGGCGAGATCATCATGCCCGCGATGACCTACGTGGCCACCGCACATGCCGCCTCGATGCTGGGGCTGACGCCGGTCTTCGCCGACGTCGATCCGGAGACCGGATGTCTCGACCCGCAGCAGGTGGAGACGGTGCTGACCCCGCGTACCTCGGGCATCGTCGGAGTTCACCTCTGGGGCCGGCCCAGCCCGGCGGGTGAGCTGGAGAAGGTAGCTGCCGCGCACGGCCTCACGCTCGTCTTCGACGCGGCGCACGCACTGGGGTGTAGCCATCAGGGCCGCCGGATCGGTGGTTTCGGTAGCGCGGAGATGTTCAGTTTCCACGCCACCAAGGTGGTCAACTGTTTCGAGGGCGGTGCGGTGGCGACCAACGACGACGCTCTCGCCGGGGAGCTTCGCGCGCTGCGTACCTTTGGGATCACCACCGACGGCCGTAGCGTGGGGGTCGGCACCAACGCCAAGATGACCGAGGCCTCCGCGGCGATGGGACTGACCTCGCTGGACGCACTGGCTACCACGGTGCGCCACAATCGGGCCAACCACGCACGCTACTGTGCCGCGCTGCGCGGACTGGGCGGCCTGACTGTCGTCGACTTCGACGAGGCCCAGGAGCCCAACCGGCAGTACGTCATCCTCAAGATCGACGAAGCGGTGACGGGCATCCATCGCGACCTGGTGATGCGGATACTCCGAGCGGAGAATGCCGGCGCGCAGCGCTATTTCTCCCCGGGCTGTCACCAGCTGGAGCCCTACCGGTCCCAGCGGCCGGTCTCTCTGCCGCACACCGAGCGCCTGGCGGAGCAGGTCCTCGCCCTGCCGACCGGCCCGGCGGTCTGCGCGGCGGATATTGACCGAATCTGCAGCATCGTGCGCTGCGCGATCTCCCACGGACCGGAGCTCGCCAACCGGCTTGGCCCGAGCCCCACCCGCCCCTTCGCCACCTCCTAG	MKDTVADLAILGGTPTFPQMLQVGTPSVGERSRLFERLHTALDNKWLTNGALVREFEERIATLAGVRHCVATCSGTMALQLLYQATELTGEIIMPAMTYVATAHAASMLGLTPVFADVDPETGCLDPQQVETVLTPRTSGIVGVHLWGRPSPAGELEKVAAAHGLTLVFDAAHALGCSHQGRRIGGFGSAEMFSFHATKVVNCFEGGAVATNDDALAGELRALRTFGITTDGRSVGVGTNAKMTEASAAMGLTSLDALATTVRHNRANHARYCAALRGLGGLTVVDFDEAQEPNRQYVILKIDEAVTGIHRDLVMRILRAENAGAQRYFSPGCHQLEPYRSQRPVSLPHTERLAEQVLALPTGPAVCAADIDRICSIVRCAISHGPELANRLGPSPTRPFATS	MRTSPSSQLSLHGVTKRYDDRVVLSQVSLAISPGEKAGIIGDNGAGKSTLLRLLAGEERPDAGEVTVIAPGGVGYLPQTLGLPPRATVQDAIDLAMTELRVLEAELRRTEAALAEAATDEALQDALTAYARLTEQYEVRDGYGADARVDAALHGLGLPGLPRDRRLGTLSGGERSRLALAATLASQPELLLLDEPTNDLDDRAVHWLEEHLSGHRGTVVTVTHDRVFLDRLTATVLEVDGRGVSRHGDGYAGYLAAKAAERRRRQQQYDEWRAELDRNRRLAEANVARLDGIPRKMGKAAFGHGAFRARGRDHGAMSRVRNAKERVERLTANPVAPPADRLSLTARIATADGPGEAPAAELDGVVVGSRLRVPKLRLGAAERLLITGPNGAGKSTLLSVLAGELSPDAGAVSVPGRVGHLRQEETPWPAKLTVLEAFAHNRPGDRDEQADRRLSLGLFEPEALRLRVGELSYGQRRRIELARLVSEPVGLLLLDEPTNHLSPALVEELEEALTGYGGALVLVTHDRRMRSRFTGSHLELREGVVSGAR	73.54	gnl|BL_ORD_ID|1841|hsp_num:0	1997			432	531	lincomycin; tylosin; mycinamicin
BGC0000240.1|Lomaiviticin_19 # 18988 # 20004 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.682	BGC0000240.1|Lomaiviticin_19 	18988	20004	+	Loose	1200	44.669	arnA	25.0	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGAGAATCCTCGTGACCGGGGGAGCCGGCTTCGTCGGCTCGCAGTACGTACGTAACCTCCTCGACGGCGTCTACCAGGGGTACGAGAACGCGGAGATCACCGTCCTGGACCTCCTCACGTACGCGGGGCGCCGGGCGAACCTGCCGGTGGCGGACCGTCGGCTGACCTTCGTCCGGGGCGACATCGGTGACCGGGGCCTCCTTCTCGACCTGCTGCCGGGGCAGGACGCGGTCGTCCACTTCGCGGCCGAAAGCCACGTGGACCGGTCACTACAGGACGCGTCGCCGTTCCTGGCGACCAACGTGCTGGGTACCCAGAACCTGCTGGAGTGCTGCCTGCGTCTCGGTATCGAACGGATCGTGCAGGTCTCGACGGATGAGGTCTACGGCACCATCGCGGAAGGCGCCTGGACGGAGGAGAATCCGCTCCGGCCGAACTCCCCGTACGCCGCCTCGAAGGCTGCGGCCGATCTGCTCGCCCGCGCCTATCACCGCTCCTACGGGCTGCCGGTGGTGATCACTCGCTGCACCAACAACTATGGGCCGTACCAGCATGTCGAGAAGGTGATCCCGCGGTTCGTCACCAACCTGCTGACCGGCCAGCCGGTGCCGCTCTACGGAGATGGCCAGAATGTCCGGGAGTGGCTGCACGTCGCGGACCACTGCCGCGGGGTGCAGCTGGCGCTGGAGCAGGGGCGCGCGGGTGAGATCTACCATCTCAGTGGTGGAGTTGAGCTGACCAACCGAGAGCTCACCGCACTCCTCGTGGAGCTCTGCGGAGCCAGCTGGGACGCGGTTCGGTTCGTCGCCGACCGGTTGGGACACGACCGGCGCTACAGCCTCGACGACGGCAAGGCCCGCCACGAACTCGGCTACGCCCCGCAGGTGTCGTTCGAATCGGGCCTGGCCGCGGTTGTGAACTGGTACCGCGACAACCGCGACTGGTGGGCGGAGCGTACGCGCGACCCGCGACCAGCCCGGGAGAGCGCCGGCTCGAGCATGGCGGTGCCCCGGTGA	MRILVTGGAGFVGSQYVRNLLDGVYQGYENAEITVLDLLTYAGRRANLPVADRRLTFVRGDIGDRGLLLDLLPGQDAVVHFAAESHVDRSLQDASPFLATNVLGTQNLLECCLRLGIERIVQVSTDEVYGTIAEGAWTEENPLRPNSPYAASKAAADLLARAYHRSYGLPVVITRCTNNYGPYQHVEKVIPRFVTNLLTGQPVPLYGDGQNVREWLHVADHCRGVQLALEQGRAGEIYHLSGGVELTNRELTALLVELCGASWDAVRFVADRLGHDRRYSLDDGKARHELGYAPQVSFESGLAAVVNWYRDNRDWWAERTRDPRPARESAGSSMAVPR	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	51.06	gnl|BL_ORD_ID|1513|hsp_num:0	1643			954	1629	polymyxin B
BGC0000240.1|Lomaiviticin_20 # 20001 # 21272 # 1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.699	BGC0000240.1|Lomaiviticin_20 	20001	21272	+	Loose	750	204.912	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	38.94	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGAGCGCACCAAGGGTCGTGATCACGGGCCTCGGCGTCGTGGCGCCCGGCGGTGTGGGTACGAAGGCGTTCTGGCACCTGATCACCGCCGGCCGGACCGCGACCCGGCCGATCACCGCTTTCGACGCTGCCGCGTTCCGGTCGCGGATCGCCGCCGAGGTTGACTTCGAGGCGGCGCAGGCGGAGCTGTCCCACCGAGAGCGTCGTCGACTGGACCGAGCCGCCCAGTTCGCCCTGGTCGCGACGAGGGAGGCGATCGCCGACGGTGGCCTGGAGCCGGACCGGTTCGATCCCACCCGGGTTGGGGTGAGTCTCGGCACTGCCGTCGGTGCCACCTGCAACCTGGAATCCGAGTATCTCGCCCTCAGCGACACCGGGCGGGAGTGGGTCCTGGATCACCGGTATGCCAGCCCACACCTCTACGACTACTTCATGCCCGGCTCGATGGCGGCGGAAATCGCCGCGGAGTGCAACGCCCAGGGTCCAGTCACTGTGGTCTCGGCGGGATGCACCTCCGGCCTGGACGCGGTCGGCCACGCGGCCGATCTGATCCGGGAGGGCGCCGCCGACGTGATGGTCACCGGCGGTACCGACGCGCCCATCTCGCCGATCACGGTCGCCTGTTTCGACGCCATTCGGGCGACCTCACCGAGTAACGACGATGCCGCACACGCGTTGCGGCCCTTTGATCGCACCCGGAACGGCTTCGTTCTCGGCGAGGGCGCCGCCACGCTGTTGCTGGAGACCGAGGAGCACGCGCGGGCCCGCGGCGCCCGGATCTATGCCGAGATCGCCGGCTTCGCCTCGCGGAGTAACGCCTACCATATGACGGGCCTGCGGCCCGACGGCGCCGAGATGGCCGCCGCCATCACCGCCGCCCTGGCCGAGAGCCGGCGCTCGCCCCAGTCCATTGACTACGTCAACGCCCACGGCACGGCGACCAAACAGAACGATCGCCATGAGACCGCCGCGCTCAAACGGGCACTCGGTCCGCACGCGTACCGGACGCCGGTCAGCTCGATCAAATCGATGATCGGTCATTCGCTCGGGGCCATCGGCTCGATCGAGATCGCCGCCTGCACCCTCGCCCTCGACCAGGGTGTTGTCCCACCCACCGCGAACCTGCGCGAGCCGGATCCGGAGCTCGACCTGGACTACGTCCCGCTACACGCCCGGGAGCAGCGGCTCGACACGGTGTTGAGCGTCGGCAGCGGCTTCGGCGGCTTCCAGAGCGCGATCGTGCTCACCCGGTTGGGCACGGGACCGGCATGA	MSAPRVVITGLGVVAPGGVGTKAFWHLITAGRTATRPITAFDAAAFRSRIAAEVDFEAAQAELSHRERRRLDRAAQFALVATREAIADGGLEPDRFDPTRVGVSLGTAVGATCNLESEYLALSDTGREWVLDHRYASPHLYDYFMPGSMAAEIAAECNAQGPVTVVSAGCTSGLDAVGHAADLIREGAADVMVTGGTDAPISPITVACFDAIRATSPSNDDAAHALRPFDRTRNGFVLGEGAATLLLETEEHARARGARIYAEIAGFASRSNAYHMTGLRPDGAEMAAAITAALAESRRSPQSIDYVNAHGTATKQNDRHETAALKRALGPHAYRTPVSSIKSMIGHSLGAIGSIEIAACTLALDQGVVPPTANLREPDPELDLDYVPLHAREQRLDTVLSVGSGFGGFQSAIVLTRLGTGPA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	101.68	gnl|BL_ORD_ID|1968|hsp_num:0	1943			309	1245	isoniazid
BGC0000240.1|Lomaiviticin_21 # 21269 # 22597 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.727	BGC0000240.1|Lomaiviticin_21 	21269	22597	+	Loose	750	97.0561	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	30.73	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGACCACAGCGGTGATCACCGGCATCGGCGTCGCGGCGCCGAACGGCGCCGGGACCGAGAACTTCTGGGCCGCGACGCTCCGCGGCGAATCCGGCATCGGCCCGATCCGCCGCTTCGACACACGGGGCTATCCGGCTCGACTGGGTGGCGAGATCGACGACTTCGACCCGGCGGAGCACCTGCCCCGCCGGCTGCTACCACAGACCGACCGGATGACCCAGCTCGCCCTCACGGCGTCGGCGTGGGCGTTGGCCGACTCCGGGGTGGCGCCGGGCACCTACGACCCGGGCGAGACCGGGGTGGCGATGGCCGGGGCGTTCGGCGGCTTCGAGTACGGCCAGCGGGAGCTGGAGAACCTCTGGTGTTCCGGCCCGGAGCGCGTCAGTGTCTACATGTCGTTTGCCTGGTTCTACGCCGTCAACACCGGGCAGCTGTCCATCCGGCACGCCCTGCGGGGCCCGGCCGGCGTCGTCGTCGGTGACCAGGCCGGCGGGCTCGACGCGGTGGCGCAGGCCCGGCGTAACATCCGCAAGGGGGCGCGGCTGATGCTCTCCGGCGGCTTCGACAGCTCCTTCTGTCCGTACGGGTGGGTCGCCCGGATCAGCGACGGGACGCTGAGCACCGACGAGGATCCGCGTACCGCCTATCTTCCCTTCGACCTCCGCGCCCGGGGTCAGGTCCCCGGCGAGGGGGGTGCGGTCCTGGTGGTCGAGGAGGCCGCCGCGGCCCGCCGTCGCGGTACCCGGATCTACGGGGAGATCGCCGGGTACGCCGCGACGTTCGACGCCGCGGCCCGGTACGGCGGTGAGCGGGGTCTGGGCCGCGCGGTGGAGGCCGCTCTCGCCGATGCGGGGGTGACCGCCCGGGAGGTCGGGGTGGTCTTCGCAGACGGTTCCGGGCGGCCGGCCGACGACCGCGCCGAGGCCGAGACCATCGCGGCTGTCTTCGGTCCGCAGGGGGTGCCGGTCACGGTCCCGAAGACCATGACCGGACGGATGAGCTCCGGTGGCGCCCCGGTCGACCTCGCCGGTGCGCTGCTGGCGATGCGAGACGGGCTTATCCCGCCGACGGTCAATGTGCGAACGGTGGCCCCGGGCGCGCGGCTGGATCTCGTCACCGGTGTTCCCCGGCCGTGGCAGCCGGGACCTGCGTTGGTGCTGGCGCGGGGCCGGGGTGGTTTCAACTCCGCCATGGTGCTCCGGCCTGGCACCGCGGCTCCCAACCGCACCGGAGCAGCCAGCGTCACCGGCCGCGAAGCACCCACCCGATCAGGAGGGAAACGTCATGAAGCAGATGACACTGTCGGCCCTGGAGGAGATCATGCATAG	MTTAVITGIGVAAPNGAGTENFWAATLRGESGIGPIRRFDTRGYPARLGGEIDDFDPAEHLPRRLLPQTDRMTQLALTASAWALADSGVAPGTYDPGETGVAMAGAFGGFEYGQRELENLWCSGPERVSVYMSFAWFYAVNTGQLSIRHALRGPAGVVVGDQAGGLDAVAQARRNIRKGARLMLSGGFDSSFCPYGWVARISDGTLSTDEDPRTAYLPFDLRARGQVPGEGGAVLVVEEAAAARRRGTRIYGEIAGYAATFDAAARYGGERGLGRAVEAALADAGVTAREVGVVFADGSGRPADDRAEAETIAAVFGPQGVPVTVPKTMTGRMSSGGAPVDLAGALLAMRDGLIPPTVNVRTVAPGARLDLVTGVPRPWQPGPALVLARGRGGFNSAMVLRPGTAAPNRTGAASVTGREAPTRSGGKRHEADDTVGPGGDHA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	106.25	gnl|BL_ORD_ID|1968|hsp_num:0	1943			87	1239	isoniazid
BGC0000240.1|Lomaiviticin_22 # 22554 # 22808 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=9bp;gc_cont=0.643	BGC0000240.1|Lomaiviticin_22 	22554	22808	+	Loose	700	24.2534	CMY-109	43.48	3002121	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGAAGCAGATGACACTGTCGGCCCTGGAGGAGATCATGCATAGGTGCGCGGGGGACGACGAGTCCACGGATTCGTTCCAACAAGCCCCCGAACGGGCCTTCGCCGACCTCGGCTACGACTCTCTCGCGCTCCTGGAGACCCAGAGCGTGATTCGGCGCGAGTACGGCGTTGACCTCTCCGAGCAGGCGTTGGGAGCGGCGGAGACGCCGCAGCAGTTGGTTGACCTCGTGAACCGATGGCTGTCGGCCGTCTGA	MKQMTLSALEEIMHRCAGDDESTDSFQQAPERAFADLGYDSLALLETQSVIRREYGVDLSEQALGAAETPQQLVDLVNRWLSAV	MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYKGKPYYFTWGKADIANNHPVTQHTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMAHWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPARVEAAWRILEKLQ	22.05	gnl|BL_ORD_ID|3401|hsp_num:0	4470			42	111	
BGC0000240.1|Lomaiviticin_23 # 22790 # 23773 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.732	BGC0000240.1|Lomaiviticin_23 	22790	23773	+	Loose	400	27.7202	ErmR	56.25	3000594	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGCTGTCGGCCGTCTGACCGGCCCGCTGGCCCTGCTGATGCCGGGCCAGAGCGCCCAGTACCAGGGGATGGGCAGCGGGCTGTACCGCGATGTACCGGAGTTCGCGCAGCTCATGGACGAGCTGTTCCTGCTGATGGGGGCGGCCGGAGACGAGCTCCGTTCGGACTGGCTCGCCGCTTCGCCCCGGGTACCTATCGACCATGCCGACCGCTCCCAGCCGTTACTCTTCGCCATCGACTATGCGCTCGGCCGGCTCCTGATGGATTGGGGACTGCGCCCGACAGTTCTACTCGGGCACAGCATCGGCGAGCTGGCCGCGGCGACGCTGGCCGGGATCTTCGATCCGGCCAGCGCGGTCCGGATCGTGCGGCACCGGGTCGGTCAGTTCGCGACGGTGCCGGCGGGCGGGATGGCCGCCGTCGCCGCGTCCCGAGCGCAGGTGCAGCCCCACCTCCGGCCGGGGGTCGACATCGGCGCGATCAACGCGCCCCGGCAGACCGTGATCGCGGGGGCGGCCGAACCACTGCGGACCACCCTGGCCACGCTCCGGCGGGCAGGCTTCACCTCGGCGCCGGTGCCGTCAACGGTGCCGTTCCACAGCGAGCTACTCCGTCCGGTGGCCGTCGCAGCTGGTCCGTTGCTGGCCAGCCTGCCGGTCCGGTCGCCACAGATACCCCTGGTTTCCGGGTACACCGCCGGCTACCTGACCGACGCCGAGGCGCGGGATCCCGGGTACTGGGCGCGTCAACCGGTGGACCCGGTGCTGTTCTGGCCGGCCTTGACGACCCTGGCGGACGCCGGGCCGCAGCTGCTGGTCGAGTCTGGCCCGGGGAACGGCCTGACGACACTCGCGCGGCGGCTGCCGCAGGTTCGCTCCGGGCACAGCGAGGTGCTGGCGCTGCTCGGCCCGCCGACGGGTCCGTCCCGGGAGGCCGAGCAGCTCGCCGCCGCCGCTGCCCGCCTCGGGATCTCCCCGCCCTGA	MAVGRLTGPLALLMPGQSAQYQGMGSGLYRDVPEFAQLMDELFLLMGAAGDELRSDWLAASPRVPIDHADRSQPLLFAIDYALGRLLMDWGLRPTVLLGHSIGELAAATLAGIFDPASAVRIVRHRVGQFATVPAGGMAAVAASRAQVQPHLRPGVDIGAINAPRQTVIAGAAEPLRTTLATLRRAGFTSAPVPSTVPFHSELLRPVAVAAGPLLASLPVRSPQIPLVSGYTAGYLTDAEARDPGYWARQPVDPVLFWPALTTLADAGPQLLVESGPGNGLTTLARRLPQVRSGHSEVLALLGPPTGPSREAEQLAAAAARLGISPP	MAGPQDRPRGRGPSSGRPQRPVGGRSQRDRDRRVLGQNFLRDPATIRRIADAADVDPDGLVVEAGPGEGLLTRELARRAGRVRTYELDQRLARRLSTDLAQETSIEVVHADFLTAPHPEEPFQFVGAIPYGITSAIVDWCLTAPTLTSATLVTQQEFARKRTGDYGRWTALTVTTWPTFEWQYVAKVDRTLFTPVPRVHSAIMRLRRRPQPLLRDAAARSRFADMVEIGFVGKGGSLYRSLTREWPRSKVDSAFARADVHHDEIVAFVHPDQWITLFQLLDGSRGGAARGPGDQRGRRGRPGGGPRPDGRAGGGPRRDAGGRRTGDGRGGRPRPPRGGQA	96.18	gnl|BL_ORD_ID|1473|hsp_num:0	1612			156	252	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000240.1|Lomaiviticin_25 # 24829 # 25152 # -1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.648	BGC0000240.1|Lomaiviticin_25 	24829	25152	-	Loose	1450	23.0978	BahA	43.33	3003984	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic inactivation	Bah amidohydrolase	ATGCGATCCGAAAACGGTTCGGATGGGGCACCGGGCGCCGGCAGCCACATCGACCGCAGGGCGAAGGAGTCGTTCGTGCCGCCGATCACGTTGCGGGAGCTCGAGCTCCTCATGCGCCAGTACGTCTGGGACGGGGACTGGCAGTCGTTCGAGCACGCCCCAGACCAGCCCTTTGACGAGCTGGGGTACGACTCGCTGGCGCTGCTGGAGACGCACAGCCGGATCAAACGCGACTACGGCGTCCTGATCTCCGAGGACGACCTGGAGCGCGTCCACACACCCCGGGCGCTGGTCGATTTCATCAATGACCACCTCGGTTCGTAA	MRSENGSDGAPGAGSHIDRRAKESFVPPITLRELELLMRQYVWDGDWQSFEHAPDQPFDELGYDSLALLETHSRIKRDYGVLISEDDLERVHTPRALVDFINDHLGS	MEIHKEKEKEKGVTFFRRIMANRKRRGPLSPGWKGASLGLGATGFILILIQANYLLTGHGVGKFIVGTFLFLFAAALISGLASMLLHGVKKLPSRYIWMLLYSLIMFLFCFIVQPGVSAVFIVSLAIVLSLFGALAYKFAAGSYKQVSKTRKIGAMACLSLITIAIGAGSFWLIRAGDDAAPDITLKQLKTSTRYEDSTMNNPAEQGTYPVQSLLYGSPDNYRTEFNQSGSLTTQTVDASRFVEKWSSLRTKSLGFGPEAMPLNGRVWYPEGEGTFPLVLIVHGNHLMNDYSDPGYEYLGRLLASKGYIFVSVDENFLNFSPYEDLFLISPLLSENPARGLLLLEHLQTWKDWNSDPDNPFYQKVDMERIALIGHSRGGEAVAIAAAYNKLGRHPDHGDIKFDYNFSIRSLISIAGTDGQYKPQGKPLPLQDVNYLSLHGAHDMDVNSLDGAKQYHRIRYTKGTNYMKSLVYIYGANHGQFNGGWGRGDGAGLGNQLFNLRQIMPRDEQETIAKVFISSFLDATLKDQRQYREVFKDLGYAKEWIPDNLYVGNYYDSQTTLIADFHEDIDLQSTTLPGGSLRGENLQQWKEEKVKTKWGEADYSAVRLGWNSNGSSEPASYTVTLPDNGVETGRDSSIVFSLADARKTEESGDPKELINFTITVEDRKGHQASLPLSHISKLPPVIEGKLLKWPFSNAGNTSEPVFQSYDFQLDDYYKMNPDFNPQQLSKIRIEFNLTKRGSILLRDVGIRS	14.23	gnl|BL_ORD_ID|2229|hsp_num:0	2521			492	582	bacitracin
BGC0000240.1|Lomaiviticin_26 # 25264 # 25725 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=12bp;gc_cont=0.690	BGC0000240.1|Lomaiviticin_26 	25264	25725	+	Loose	230	56.9954	ramA	34.38	3000823	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	ATGTGCGTGCGTGCTCAGCAGCCGAACCCGGACGAGGTTCGATCCCGCCTGCGCCATCTCGCGCGACTGCGGCAGGTCCGGGACCGTATCGACCGGGAGTACGCGCAGCCGCTGGACGTGCAGGCGTTAGCCCGCGGAGTGAACATGTCCGCCGGGCATCTAAGCCGTGAGTTCCGCCTTGCCTACGGTGAGTCGCCGTACGCGTACCTGCTGACCCGGCGGGTGGAGCGGGCGATGACACTACTGCGACGCGGCGACATGACCGTAACGGAGGTCTGCTTCGCGGTCGGCTCCTCCTCGCTGGGGACGTTCAGCACGCGCTTCACCGAACTGGTGGGCGTGCCCCCCAGCACGTACCGACGGATGGCGTCGGAGGCGACGGCGGGGATGCCGTCGTGTGTGTCGAAGCAGGTGACTCGGCCGGTGCGGAGCCGATCGGCGGGGGAGCGGCAACCGGTCTGA	MCVRAQQPNPDEVRSRLRHLARLRQVRDRIDREYAQPLDVQALARGVNMSAGHLSREFRLAYGESPYAYLLTRRVERAMTLLRRGDMTVTEVCFAVGSSSLGTFSTRFTELVGVPPSTYRRMASEATAGMPSCVSKQVTRPVRSRSAGERQPV	MINQEAEGESSMTISAQIIDTIVEWIDDNLHQPLRIEEIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLLLAARDLRESDARVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENHSRAH	123.39	gnl|BL_ORD_ID|1537|hsp_num:0	1665			63	351	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000240.1|Lomaiviticin_27 # 25892 # 26779 # 1 # ID=1_27;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=10bp;gc_cont=0.651	BGC0000240.1|Lomaiviticin_27 	25892	26779	+	Loose	200	26.5646	FosX	35.9	3000198	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	GTGAGGAGGACTCAGGTGAAGGGCATCGTCCTGGCCGGCGGCTCGGGGACGCGGCTGCACCCGGTGACCCTGGCGCTGTCGAAACAGCTTCTGCCGGTCTACAACAAACCGATGATCTACTATCCCCTCTCGGTGCTCATGCTCACCGGGATCCGGGACATCCTGATCATTTCCACGCCACGGGACCTGCCGTTGTTCGAGCGGCTTCTCGGCGACGGTTCCCGGTTCGGCCTGTCGATCTCGTACGCCGCCCAGCCGGTTCCGCGGGGCCTGGCTGACGCCTTCGTCATCGGTGCGGAGCACGTCGGACCCGACCCGGTCGCCCTCATTCTGGGCGACAACATCTTCCACGGCTATCGGTTCTCGGAGCGGCTGCAGGCGGAGAGCCGGGATATCGACGGGTGCGTGTTGTTCGGCTACCCGGTCACCGATCCGCAGCGGTACGGGGTGGGGGAGACCGACGCGACGGGTCGGCTCATCTCCATCGAGGAGAAGCCACGTAGGCCCCGATCCAATCGGGCGATCACCGGGTTGTACTTCTACGACAACGACGTGGTGGACATCGCCAAGAATGTTCGCCCGTCGGCGCGGAACGAGGTCGAGATCACCCGAGTCAACCAGGTCTACCTGGAGCGGGGTAAGGCGAGACTGGTCGATCTGGGTCGTGGGCTGGCCTGGCTGGATGCCGGCACCTACGACTCGTTGCTCCAGGCCAGTCACTACCTGCAGACCCTGGAGCAGCGGCAGGGCATTCATATCGCCTGTCTGGAGGAGGTGGCCCTGCGGATGGGTTTCATCGACGCCGAGGCCTGTCACGCTCTCGGTGCCGAGTTGGCGCATACCGACTACGGCCGGTACGTCCTGAACGTGGCGGCGCAAGCACGCTGA	MRRTQVKGIVLAGGSGTRLHPVTLALSKQLLPVYNKPMIYYPLSVLMLTGIRDILIISTPRDLPLFERLLGDGSRFGLSISYAAQPVPRGLADAFVIGAEHVGPDPVALILGDNIFHGYRFSERLQAESRDIDGCVLFGYPVTDPQRYGVGETDATGRLISIEEKPRRPRSNRAITGLYFYDNDVVDIAKNVRPSARNEVEITRVNQVYLERGKARLVDLGRGLAWLDAGTYDSLLQASHYLQTLEQRQGIHIACLEEVALRMGFIDAEACHALGAELAHTDYGRYVLNVAAQAR	MISGLSHITLIVKDLNKTTAFLQNIFNAEEIYSSGDKTFSLSKEKFFLIAGLWICIMEGDSLQERTYNHIAFQIQSEEVDEYTERIKALGVEMKPERPRVQGEGRSIYFYDFDNHLFELHAGTLEERLKRYHE	221.80	gnl|BL_ORD_ID|111|hsp_num:0	129			222	339	fosfomycin
BGC0000240.1|Lomaiviticin_28 # 26840 # 28303 # -1 # ID=1_28;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.685	BGC0000240.1|Lomaiviticin_28 	26840	28303	-	Loose	1050	159.073	facT	31.68	3001313	protein homolog model	n/a	n/a	elfamycin antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGACCACGGAGCATCAGCGGGGACTGCCCCGGACCGGATCCGGTCGTCCGGTGCCGCGGGGCCCGGTGGTGGTGGTGAGTGCGCTGATCACCTTTATCGCCGGGCTCAACATCGCCCTGGTGGTGATCGCGATGCCAACGATCCGCACGGCGCTCGAGTTGGATTCGAGTACCCAGCAGTGGCTGGTGTCGGCGTTCTACCTGGCGATCGGCCTGGTGCTGGTGCCCGCGGGCCGATTCGGTGACATACACGGCCGGCGCAACATCTTCGTGACCGGCGTGGTGGCGTTCGTGGTGGCCAGCGCAACCGCGGCGTTGGCCACACACGAGGCGTGGCTGATCGCCGCCCGACTGGTTCAGGGTGCGGGCATCGGGCTGGCGCTCGCCCAGGTGTTAGGGACAATCCAGCGGATATTCTCCCCCCGGGAACGGGGATTCCCGTTCGGAGCGGTCACCGCCGGGATCAGCGTCGCCCGGCTGATCGGCCCGGTACTCGGCGGCGGGTTCATCGCCGTCGGGGGCGCCGAGTGGGGCTGGCGGTGGGCCTTTCTGGTCAACGTGCCGATCGGGGTCGTCATCGCGGTTCTCGGGTGGCGATTGCTCCCCGTCGCGGAGCGGGCCGAGCGGCCACGAATGGACCTGGTGGGCGCCGTCCTGTTGACGGTCGGGCTGGGCTTTCTGTGGCTGGTCCAGGGTGAGCAGATGCCGGGTTGGTTGACCTGGACGCTCCTGGCCACGGCGGTGGCGGTGCTGGTGGGGTTCGTGCGCTGGGAGACGCGATACGCCCGGCACGGTGAACCGATGTTCAACATGAGGCTGTTCCGGTTCCGCTCCTTCTCGGCGGGGATCATCATCGCCATCTGCTACACCGCCGGCTACGACGGCATCTACTACCTGATGTCGGAATATCTGCAACACGGACTCGGTCATGACGAGTTGGTGACCGGGATCGCGCTCACCCCACTGGCCCTGGGGGCCGCCATCAGTGCCGTGATCGCCGGGTCCAAGGCGGGGCGGTTCGGCAAACCGTTGGTGGTTTCGGGCCTACTCCTCGCGGGGGTCGGGCTCACCGCCCTACTCGTCGCCGACCTCTTTCTTCCCGACCCGGACTCCCCGCACGCGGCCACGCTGCCGCTGCTTCTGGTCGGGCTGGGTGGCGGACTGATCACCTCGGGGGTGGCCGGCGGCCTGGTGATCGCCCCGAACCTGACCGTTGCCCTCTCTCCCGTGCCACAGACCCAGGGCGGAAGCGCTGGCGGGATGCTCGAGGCCGGGCAGGCACTCGGTGGCGGGCTGGGCGTTGGTCTCGTCGGTGCGGCCCTCTTCGCGAGCCTCGACCGGACCGGCGACTGGTTGACCGCCTTCCGCATACCAGTGCTGGTCATCGTCGGGCTCTTCGCCGTCGCCCTGACAGCAGCCCTGATCAATCTCTTCTCGCCCGACCGTTCCGTTCCGTCCGCATAA	MTTEHQRGLPRTGSGRPVPRGPVVVVSALITFIAGLNIALVVIAMPTIRTALELDSSTQQWLVSAFYLAIGLVLVPAGRFGDIHGRRNIFVTGVVAFVVASATAALATHEAWLIAARLVQGAGIGLALAQVLGTIQRIFSPRERGFPFGAVTAGISVARLIGPVLGGGFIAVGGAEWGWRWAFLVNVPIGVVIAVLGWRLLPVAERAERPRMDLVGAVLLTVGLGFLWLVQGEQMPGWLTWTLLATAVAVLVGFVRWETRYARHGEPMFNMRLFRFRSFSAGIIIAICYTAGYDGIYYLMSEYLQHGLGHDELVTGIALTPLALGAAISAVIAGSKAGRFGKPLVVSGLLLAGVGLTALLVADLFLPDPDSPHAATLPLLLVGLGGGLITSGVAGGLVIAPNLTVALSPVPQTQGGSAGGMLEAGQALGGGLGVGLVGAALFASLDRTGDWLTAFRIPVLVIVGLFAVALTAALINLFSPDRSVPSA	MNKAGQAEKPAAAGPPATPETPEPDPKRWLALTVLLVATFMDLLDANIITVAIPSIQRDLGASTFAIQAMTAGYTLSFAVLLITGGRLGDIFGRKRMFLVGVGGFVLASAMCAAAPSTDLLVVARALQGLTAAVMVPQVLALIHVSFAPQEIGRVVSLYASMVGLAIVSGPLIGGALISWNPLDLGWRSIFVVNLPVGVLALVGAAKWMRESSSPHAKRLDIAGMLLIVLGLLLLMVPLTLGRELDWPVWSIVSLVAAAPVLVLFVVYERHKTAKDGSPLVTLSLFKVRAFGAGIGVQLLFSAIPAGFFLSWTLYLQAGLGWSALHTGLTAIPFSLCVPIVGGLAVRRLSPLYGRYCLLAGAVLMLAGILSYAWAADRFGTDITSWHAIPSMLLIGSGMGMLMPPLTALVLREVQPQEAGAASGIINATGQLGAALGVAVIGSLFFAALAGNAGPQAERVAPTVQSVSPRQASDLRDCATEALGQDDLAKVPDICSTLVQGADDGTRDTINGALGEIRAKTFVSTYSETLYWAAGGLVPVTALVLLLPHHRVRREEPAQ	87.12	gnl|BL_ORD_ID|1345|hsp_num:0	1469			114	1347	factumycin
BGC0000240.1|Lomaiviticin_29 # 28614 # 29255 # 1 # ID=1_29;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.723	BGC0000240.1|Lomaiviticin_29 	28614	29255	+	Loose	450	25.0238	aadA2	50.0	3002602	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	GTGGACAGCGAGAAGCTGTGGGACATCGCGCTGCGCGAGCTGGCAGTCACCTACGGCGGCGTGCTCTCCGAGACCACCCGGCGGGCCATGATCGGAACGAGCATGGCGGCCTCGATGCAACTCCTCCACGAGGACCTGGGCCAGCCGGAACGCGACCTGCAGGCCAGTGCCGCGTGGATCAACGCGCGGATCCTGGAGCTGTTCGGCGACGGGCTGCAGTGGCGGCCGGGCGCGCTGACCCTGCTGCGCGCCGTCCGTGCCGCGCGGATCCCGACAGCCCTGGTCACCTCCAGCGCTCGGACGTTGGTGGAGGTTGCCCTCGACACCCTGGGGCGGGACAGCTTCGACGCGGTGGTGTGCGGGGACGAGGTGGACGCGGCCAAACCACACCCGATGCCCTACCTGACCGCGGCCCGGCTGCTCGGCGTGCCGATCGGCCGCTGCGTGGCGATCGAGGACTCCCCGGCCGGGGTGGCGAGTGCCCTCGCCGCGGGTGCGGCGGTACTCGCGGTACCGGCGGAGGTGCCGGTGGAGCCCTGCGCCGACGTACACCAACTGGTGAGCCTGGCCGCGGCAGACCTGGAGCTCCTGACGGCGTTGCTCGGGGAACGCTCGCGAGATGTCGCCTTCGGCGCTCGGTAG	MDSEKLWDIALRELAVTYGGVLSETTRRAMIGTSMAASMQLLHEDLGQPERDLQASAAWINARILELFGDGLQWRPGALTLLRAVRAARIPTALVTSSARTLVEVALDTLGRDSFDAVVCGDEVDAAKPHPMPYLTAARLLGVPIGRCVAIEDSPAGVASALAAGAAVLAVPAEVPVEPCADVHQLVSLAAADLELLTALLGERSRDVAFGAR	MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRALLNDLMEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAMIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVGK	82.24	gnl|BL_ORD_ID|1126|hsp_num:0	1227			132	210	spectinomycin; streptomycin
BGC0000240.1|Lomaiviticin_30 # 29326 # 31875 # -1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.697	BGC0000240.1|Lomaiviticin_30 	29326	31875	-	Loose	1280	65.855	macB	22.97	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGTTCCGGGCGACCCTCAAGAGCCTGCTGGCACGCAAGCTCCGGCTGATCCTGTCCGGGTTGGCGGTGGTACTCGGCGTCATGTTCGTCTCGGGCGCGTTCGTGCTCACCGACACCCTCGGCCGTTCCTTCGACGCCGTCTTCGCCGACGCGTACGAAGGGGTGGACGTCAACGTCTCCGCGAAGTCAAGAATGGAGGTGGGTGACTTCGAGGGTGAGGCGGTGGCGGCGCCGGTGCCGGCCGAGACGGTGGAGCGAATCCGGAACGTTGCCGGGGTGGCCGACGCCACCGGCATCGTGGCCGCCGACGGCGCGCGCCTGATCGGCAGCAACGGCAAGGTGGTCACCTCCTTCGGGCCGCCTCAAATCGGTGCGAACTGGGTGGGCACAAGCGATCTCGTCCAGCTGCGCGAGGGCCGGGAGCCGCAGGCGGACGACGAGATTCTGGTCAATGCCGGGCTGGCCAAGGCCGGCCGGGTCGCTGTCGGCGATCGAGTGGGCGTACTCACGCTCGAGCCGAAGCAGGAGTTCACCATCGTCGGGGTCTTCGGCTACAGCGGCGGCCGCGACGCCATCGGCGGCGTCAACGAGGTCATGTTCACCACTCCGGTAGCGCAGCAGTTGATGCTCGGCCAGGGCGACGCCTTCACCAACGTCACGGTCACCGCCGCCGACGGCGTCGCCAACGATCGGCTGCGCGACGACATCGCCGCCGCACTCGGGGCCGACTTCGAGGTGAAGACCGGCGCCGAGGTCTCCGCGGAGGCCTCGGCGACGCTAAAGGAGGGGTTGTCCTTCTTCAACCGAATCCTGCTCGGCTTCGCCGCGGTGGCACTGCTGGTGGGCACGTTCCTGATCCTCAACACATTTTCGATCATCGTGGCCCAGCGCACCCGGGAGTTGGCGCTGATGCGCGCCGTCGGGGCGGGCCGCCGCCAGATCATTGGCTCGGTGGTGCTGGAGGCGGTGGCGGTCGGCCTACTCGCCTCCGTGCTCGGCCTCGGCGCCGGCGTCGGCATCGGCGCGCTGCTGGCGTACCTGTTCGGCAATCTCTCCGGCGGGCTGGACCTGGCGGGAATCGCTGTGCCCCCGGCGGCGGTTGTCGGGGCGTTCGGGGTCGGCCTGATCATCACGGTGGTGGCGGCACTGCTGCCCGCGCTGCGGGCATCCCGGATTCCGCCGATCGCGGCGATGCAGGACGTCGCGACCCCGGACCGGCCGCTGACCAAGGTCACGGTGACGGGCGCGGCGGTGACCTCAATCGGCGCCACACTGCTCTTCCTGGGCCTCGGCGGGCACGCCGGCGACAACGCCCTGATCACCATCCTCGGCGGCGTGCTCTTCGCCTTCATCGGGGTGGCGCTCCTGACCCCGATGATCAGCCGGCCGGTGGTCGGTCTACTCGGCGGGATCTTCTCCTGGTGGATGCCGGGCAAGCTGGGCCGGCTCAACTCCGGACGAAACCCGCGCCGTACGGCGATCACGGCAGCCGCGCTGATGGTCGGCATCGCCCTGGTCACCGGGGTCACCGTCATTCTGGATTCCACCAAGAGCAGCATCAGCAGCCTGGCCGAGGACAAGATCAAGGCCGAGTTGGTGATCGGCGGCGCGCAGACCGGGCCCCGACCGCCGACCTTCGACCCGGCGGTGCTGGAGAAGACCGCGGCGCTGCCCGGGGTGGCGCTGGTCGGTGGAGCATACGGCGATCTGGCCCAGGTCGGCGACGAACGCACCTGGGTGGGCGCCAACAGCGACGTGTCGACGCTGACGCAGATCTTCGGCGCGCGGGCCACCGCCGGGGACATCAGTCGACTCGGGCCGGATCAGATGCTGGTCAGCTCGGATGTGGCGGCCTCGCGCGGACTCTCCGTCGGCTCCACCGTGCCGGTACAGTTGGCCCGCGCCGAGCCGAAGACCTACACGGTCAGCGGGATCTACGAAGCCGATGAGCTCCTCGATCCAATCACGTTGCCGGTCTCCGCGGCGCAGGGCTTCACCATCCCCCAGCCGATCGCGGGCTTCATCCAGCTCACGCCCGGCGCCCAGGCCGCTGACGTGCTGCCGCAGGTGGAGCCGCTCCTGGCGGACAGCCCGGAGGTGTCGGTGGCCGACCGGGAAGCGTTCATCGAGCAGCAGACCGAACCGCTCGACGGCCTGTTACGAATGATCCAGATCCTGCTGCTGTTGGCCATCGTGATCGCGGTGCTCGGCATCATCAACACCCTGGCCCTGTCGGTGCTCGAACGCACCCGGGAGCTCGGGCTGCTCCGCGCGGTCGGCCTCGGCCGGGCGCAGACCATGGGCATGATCACTGTAGAGGCAGTGGTGATCTCGGTCTTCGGTGCGCTGCTCGGCATCGCCGTCGGCGCCGGCCTCGGTGCGGCCGTCGTCGAGGCGTTGCGCGACGAGGGAATCACCGACCTGGTGTTGCCCTGGGCGGACATGGGGACGATGGTCGGCCTCGGCGCACTCGTCGGCGTCCTCGCCGCGGTGATTCCCGCGGTCCGCGCCGCCCGCATCGATGTCCTGGGCGCCATCGCCCACGACTGA	MFRATLKSLLARKLRLILSGLAVVLGVMFVSGAFVLTDTLGRSFDAVFADAYEGVDVNVSAKSRMEVGDFEGEAVAAPVPAETVERIRNVAGVADATGIVAADGARLIGSNGKVVTSFGPPQIGANWVGTSDLVQLREGREPQADDEILVNAGLAKAGRVAVGDRVGVLTLEPKQEFTIVGVFGYSGGRDAIGGVNEVMFTTPVAQQLMLGQGDAFTNVTVTAADGVANDRLRDDIAAALGADFEVKTGAEVSAEASATLKEGLSFFNRILLGFAAVALLVGTFLILNTFSIIVAQRTRELALMRAVGAGRRQIIGSVVLEAVAVGLLASVLGLGAGVGIGALLAYLFGNLSGGLDLAGIAVPPAAVVGAFGVGLIITVVAALLPALRASRIPPIAAMQDVATPDRPLTKVTVTGAAVTSIGATLLFLGLGGHAGDNALITILGGVLFAFIGVALLTPMISRPVVGLLGGIFSWWMPGKLGRLNSGRNPRRTAITAAALMVGIALVTGVTVILDSTKSSISSLAEDKIKAELVIGGAQTGPRPPTFDPAVLEKTAALPGVALVGGAYGDLAQVGDERTWVGANSDVSTLTQIFGARATAGDISRLGPDQMLVSSDVAASRGLSVGSTVPVQLARAEPKTYTVSGIYEADELLDPITLPVSAAQGFTIPQPIAGFIQLTPGAQAADVLPQVEPLLADSPEVSVADREAFIEQQTEPLDGLLRMIQILLLLAIVIAVLGIINTLALSVLERTRELGLLRAVGLGRAQTMGMITVEAVVISVFGALLGIAVGAGLGAAVVEALRDEGITDLVLPWADMGTMVGLGALVGVLAAVIPAVRAARIDVLGAIAHD	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	131.83	gnl|BL_ORD_ID|446|hsp_num:0	487			762	1932	erythromycin
BGC0000240.1|Lomaiviticin_31 # 31875 # 32642 # -1 # ID=1_31;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.674	BGC0000240.1|Lomaiviticin_31 	31875	32642	-	Loose	1280	186.037	macB	44.24	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGACCGCGACGGTAGGCCGTCAGGCGCAGGCCGCGGCCCGCGCGAGCGAGGTGTGGAAGGTGTACGGCAGCGGGGAGGCACAGGTGATCGCGCTTCGCGGGGTCAGCTGTGAGTTCGAGCAGAGCCGATTCACCGCGATCATGGGTCCATCCGGGTCGGGCAAGTCAACGTTGATGCACTGCCTCGCCGGGCTGGACTCCGTGACCCGGGGCACGGTCTCGATCGGCGAGACCACGGTCACCGGCCTGGGGGATGCCGGTCTGACGAAGCTGCGCCGCGAGCAGGTCGGATTCATCTTCCAACAGTTCAACCTGCTGCCGACGTTGACCGCAAAGGAAAACATCCTGCTGCCGCTGTCGATCGCTGGGCGCAAGCCGGACCAAGCCTGGTTCGACACGGTGATCGAGACCGTCGGCCTGCGGGATCGGCTGGATCACCGGCCGGCGCAGCTCTCCGGTGGGCAGCAGCAGCGGGTGGCGTGCGCGCGGGCACTGGTCAGCCGCCCACAGGTGATCTTCGCGGACGAGCCGACCGGCAACCTCGACTCTCGGGCCGGCGCGGAGGTGCTGAAGTTCCTCCGTAACTCGGTACGGGAGCACGGGCAGACCATTGTCATGGTCACCCATGATCCGACCGCCGCCGCCTACGCCGACCGGGTGGTCTTCCTCGCCGACGGACAGATCGTCTCCGAGCTGATCGAGCCGACGGCGGAGACGGTGCTGGACACGATGAAGAAGCTCGACACCCAGGTCGAGGTGGGCGACTGA	VTATVGRQAQAAARASEVWKVYGSGEAQVIALRGVSCEFEQSRFTAIMGPSGSGKSTLMHCLAGLDSVTRGTVSIGETTVTGLGDAGLTKLRREQVGFIFQQFNLLPTLTAKENILLPLSIAGRKPDQAWFDTVIETVGLRDRLDHRPAQLSGGQQQRVACARALVSRPQVIFADEPTGNLDSRAGAEVLKFLRNSVREHGQTIVMVTHDPTAAAYADRVVFLADGQIVSELIEPTAETVLDTMKKLDTQVEVGD	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	39.60	gnl|BL_ORD_ID|446|hsp_num:0	487			21	669	erythromycin
